


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:51:46Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406198" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406198</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" id="d31446009" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Chem</journal-id><journal-id journal-id-type="iso-abbrev">J Med Chem</journal-id><journal-id journal-id-type="pmc-domain-id">822</journal-id><journal-id journal-id-type="pmc-domain">acssd</journal-id><journal-id journal-id-type="publisher-id">jm</journal-id><journal-title-group><journal-title>Journal of Medicinal Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0022-2623</issn><issn pub-type="epub">1520-4804</issn><self-uri>pubs.acs.org/jmc</self-uri><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>ACS AuthorChoice</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406198</article-id><article-id pub-id-type="pmcid-ver">PMC12406198.1</article-id><article-id pub-id-type="pmcaid">12406198</article-id><article-id pub-id-type="pmcaiid">12406198</article-id><article-id pub-id-type="pmid">40830910</article-id><article-id pub-id-type="doi">10.1021/acs.jmedchem.5c01558</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Decadentate Acyclic
Chelators for Lanthanum Radiopharmaceuticals</article-title></title-group><contrib-group id="CONTRIB-GROUP-d14e22-autogenerated"><contrib id="ath1" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7288733</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5974-4464</contrib-id><name name-style="western"><surname>Freire-Garc&#237;a</surname><given-names initials="A">Ant&#237;a</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib id="ath2" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7671280</contrib-id><name name-style="western"><surname>Babi Araujo</surname><given-names initials="Y">Yasniel</given-names></name><xref rid="aff2" ref-type="aff"/></contrib><contrib id="ath3" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">3076072</contrib-id><name name-style="western"><surname>Wuest</surname><given-names initials="M">Melinda</given-names></name><xref rid="aff2" ref-type="aff"/></contrib><contrib id="ath4" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7671284</contrib-id><name name-style="western"><surname>Szil&#225;gyi</surname><given-names initials="B">Bal&#225;zs</given-names></name><xref rid="aff3" ref-type="aff"/><xref rid="aff4" ref-type="aff"/></contrib><contrib id="ath5" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">6618369</contrib-id><name name-style="western"><surname>Madarasi</surname><given-names initials="E">Enik&#337;</given-names></name><xref rid="aff3" ref-type="aff"/><xref rid="aff4" ref-type="aff"/></contrib><contrib id="ath6" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">185463</contrib-id><name name-style="western"><surname>Valencia</surname><given-names initials="L">Laura</given-names></name><xref rid="aff5" ref-type="aff"/></contrib><contrib id="ath7" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">7671291</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9833-8928</contrib-id><name name-style="western"><surname>Argibay-Otero</surname><given-names initials="S">Saray</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="aff5" ref-type="aff"/></contrib><contrib id="ath8" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">4417845</contrib-id><name name-style="western"><surname>Rodr&#237;guez-Rodr&#237;guez</surname><given-names initials="A">Aurora</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib id="ath9" contrib-type="author"><contrib-id contrib-id-type="paragon-plus" authenticated="true">238064</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6270-1660</contrib-id><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names initials="D">David</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib id="ath10" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="paragon-plus" authenticated="true">993066</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7896-7890</contrib-id><name name-style="western"><surname>Tircs&#243;</surname><given-names initials="G">Gyula</given-names></name><xref rid="cor1" ref-type="corresp"/><xref rid="aff3" ref-type="aff"/></contrib><contrib id="ath11" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="paragon-plus" authenticated="true">1398116</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6705-6450</contrib-id><name name-style="western"><surname>Wuest</surname><given-names initials="F">Frank</given-names></name><xref rid="cor2" ref-type="corresp"/><xref rid="aff2" ref-type="aff"/></contrib><contrib id="ath12" contrib-type="author" corresp="yes"><contrib-id contrib-id-type="paragon-plus" authenticated="true">184144</contrib-id><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6989-9654</contrib-id><name name-style="western"><surname>Platas-Iglesias</surname><given-names initials="C">Carlos</given-names></name><xref rid="cor3" ref-type="corresp"/><xref rid="aff1" ref-type="aff"/></contrib><aff id="aff1">
<label>&#8224;</label>
<institution content-type="dept">CICA
-</institution>
<institution content-type="dept">Centro Interdisciplinar de Qu&#237;mica
e Biolox&#237;a and Departamento de Qu&#237;mica, Facultade de
Ciencias</institution>, <institution-wrap><institution-id institution-id-type="Ringgold" specific-use="source:pplus">16737</institution-id><institution>Universidade da Coru&#241;a</institution></institution-wrap>, <postal-code>15071</postal-code>
<city>A Coru&#241;a</city>, <state>Galicia</state>, <country country="ES">Spain</country>
</aff><aff id="aff2">
<label>&#8225;</label>
<institution content-type="dept">Department
of Oncology</institution>, <institution-wrap><institution-id institution-id-type="Ringgold" specific-use="source:pplus">3158</institution-id><institution>University of Alberta</institution></institution-wrap>, <city>Edmonton</city>, <state>Alberta</state>
<postal-code>T6G 1Z2</postal-code>, <country country="CA">Canada</country>
</aff><aff id="aff3">
<label>&#167;</label>
<institution content-type="dept">Department
of Physical Chemistry, Faculty of Science and Technology</institution>, <institution>University of Debrecen</institution>, <postal-code>H-4032</postal-code>
<city>Debrecen</city>, <country country="HU">Hungary</country>
</aff><aff id="aff4">
<label>&#8741;</label>
<institution content-type="dept">Doctoral
School of Chemistry</institution>, <institution>University of Debrecen</institution>, <postal-code>H-4032</postal-code>
<city>Debrecen</city>, <country country="HU">Hungary</country>
</aff><aff id="aff5">
<label>&#8869;</label>
<institution content-type="dept">Departamento
de Qu&#237;mica Inorg&#225;nica, Facultad de Ciencias</institution>, <institution-wrap><institution-id institution-id-type="Ringgold" specific-use="source:pplus">16784</institution-id><institution>Universidade de Vigo</institution></institution-wrap>, <addr-line>As Lagoas, Marcosende</addr-line>, <postal-code>36310</postal-code>
<city>Pontevedra</city>, <country country="ES">Spain</country>
</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>gyula.tircso@science.unideb.hu</email>.</corresp><corresp id="cor2"><label>*</label>Email: <email>wuest@ualberta.ca</email>.</corresp><corresp id="cor3"><label>*</label>Email: <email>carlos.platas.iglesias@udc.es</email>.</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>8</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><day>28</day><month>8</month><year>2025</year></pub-date><volume>68</volume><issue>16</issue><issue-id pub-id-type="pmc-issue-id">496131</issue-id><fpage>17823</fpage><lpage>17839</lpage><history><date date-type="received"><day>06</day><month>6</month><year>2025</year></date><date date-type="accepted"><day>06</day><month>8</month><year>2025</year></date><date date-type="rev-recd"><day>04</day><month>8</month><year>2025</year></date><date date-type="online"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><ali:free_to_read content-type="AuthorChoicev2" start_date="2025-08-19"/><license><ali:license_ref specific-use="textmining" content-type="ccbylicense" start_date="2025-08-19">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is licensed under CC-BY 4.0</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="jm5c01558.pdf"/><abstract><p>Two decadentate acyclic
chelators bearing four picolinic acid groups
appended on either an ethylenediamine (H<sub>4</sub>TPAEN) or a <italic toggle="yes">trans</italic>-1,2-cyclohexyldiamine (H<sub>4</sub>TPADAC) unit were
explored as candidates for lanthanum-based radiopharmaceutical development.
The two chelators form ten-coordinated complexes with La<sup>3+</sup> in the solid state, as evidenced by the corresponding X-ray structures
and solution NMR studies. The La<sup>3+</sup> complexes of TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup> are characterized
by high thermodynamic stability constants of log <italic toggle="yes">K</italic>
<sub>LaL</sub> = 19.16(8) and 19.55(1), respectively. Kinetics studies
indicate that the complexes dissociate following the acid-catalyzed
and Cu<sup>2+</sup>-assisted pathways. Quantitative radiolabeling
of both chelators with [<sup>135</sup>La]&#173;La<sup>3+</sup> was achieved
at pH &#8764; 4&#8211;5 using straightforward protocols and low
concentrations of the chelator (3 &#956;M). Both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> studies indicate that the [<sup>135</sup>La]&#173;La<sup>3+</sup> complex of TPAEN<sup>4&#8211;</sup> is significantly
more stable than the TPADAC<sup>4&#8211;</sup> analogue, with the
former remaining intact and stable even after 60 min <italic toggle="yes">in vivo</italic> when injected to healthy mice.</p></abstract><abstract abstract-type="graphical"><graphic position="float" orientation="portrait" xlink:href="jm5c01558_0015.jpg"/></abstract><abstract abstract-type="toc-graphic"><graphic id="tgr1" position="float" orientation="portrait" xlink:href="jm5c01558_0013.jpg"/></abstract><funding-group><award-group id="fnd-1"><funding-source><institution-wrap><institution>Ministerio de Ciencia, Innovaci&#243;n y Universidades</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100014440</institution-id></institution-wrap></funding-source><award-id>FPU21/06305</award-id></award-group></funding-group><funding-group><award-group id="fnd-2"><funding-source><institution-wrap><institution>Ministerio de Ciencia, Innovaci&#243;n y Universidades</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100014440</institution-id></institution-wrap></funding-source><award-id>PID2022-138335NB-I00</award-id></award-group></funding-group><funding-group><award-group id="fnd-3"><funding-source><institution-wrap><institution>European Regional Development Fund</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100008530</institution-id></institution-wrap></funding-source><award-id>PID2022- 138335NB-I00</award-id></award-group></funding-group><funding-group><award-group id="fnd-4"><funding-source><institution-wrap><institution>Debreceni Egyetem</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100009232</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group id="fnd-5"><funding-source><institution-wrap><institution>Xunta de Galicia</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100010801</institution-id></institution-wrap></funding-source><award-id>ED431C 2023/33</award-id></award-group></funding-group><funding-group><award-group id="fnd-6"><funding-source><institution-wrap><institution>Nemzeti Kutat&#225;si Fejleszt&#233;si &#233;s Innov&#225;ci&#243;s Hivatal</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/501100011019</institution-id></institution-wrap></funding-source><award-id>NKFIH K-134694</award-id></award-group></funding-group><funding-group><award-group id="fnd-7"><funding-source><institution-wrap><institution>Dianne and Irving Kipnes Foundation</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">NA</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group id="fnd-8"><funding-source><institution-wrap><institution>New Frontiers in Research Fund</institution><institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">NA</institution-id></institution-wrap></funding-source><award-id>NFRFT-2022-00269</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>jm5c01558</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>jm5c01558</meta-value></custom-meta><custom-meta><meta-name>production-flag-MathML-config-version</meta-name><meta-value>3</meta-value></custom-meta><custom-meta><meta-name>production-flag-journal-citation-display-style</meta-name><meta-value>acs-titles</meta-value></custom-meta><custom-meta><meta-name>production-flag-journal-date-display-style</meta-name><meta-value>dates-used-rcd-rvd-acc</meta-value></custom-meta><custom-meta><meta-name>production-flag-si-avail</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>document-id-alt-64</meta-name><meta-value>2188868b86f7a2349ae099ef4d36e1b221a2697d13624f53c6b4be93c5dd1559</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Lanthanum radioisotopes are promising
candidates for the development
of radiopharmaceuticals thanks to their interesting decay properties
and the possibility to combine therapeutic and diagnostic approaches.<named-content content-type="bibref-group">
<xref rid="ref1" ref-type="bibr"/>,<xref rid="ref2" ref-type="bibr"/>
</named-content> Indeed, both <sup>132</sup>La and <sup>133</sup>La are positron
emitters with great potential in positron emission tomography (PET)
due to the availability of production routes in medical cyclotrons<named-content content-type="bibref-group">
<xref rid="ref3" ref-type="bibr"/>&#8722;<xref rid="ref4" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref5" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref6" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref7" ref-type="bibr"/>
</named-content> and their moderate half-lives of 4.6 and 3.9 h, respectively.<xref rid="ref8" ref-type="bibr"/> Another short-lived positron-emitter lanthanum
radioisotope, <sup>134</sup>La (<italic toggle="yes">t</italic>
<sub>1/2</sub> =
6.5 min), can be obtained from <sup>134</sup>Ce (<italic toggle="yes">t</italic>
<sub>1/2</sub> = 3.2 d),<xref rid="ref9" ref-type="bibr"/> paving the way
for the use of the <sup>134</sup>Ce/<sup>134</sup>La pair as an <italic toggle="yes">in vivo</italic> generator.<xref rid="ref10" ref-type="bibr"/> These positron
emitting radioisotopes have been proposed as diagnostic pairs for
the <sup>225</sup>Ac and <sup>135</sup>La radiotherapeutics.<named-content content-type="bibref-group">
<xref rid="ref2" ref-type="bibr"/>,<xref rid="ref5" ref-type="bibr"/>,<xref rid="ref10" ref-type="bibr"/>&#8722;<xref rid="ref11" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref12" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref13" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref14" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref15" ref-type="bibr"/>
</named-content> The latter is an Auger-Meitner emitter with <italic toggle="yes">t</italic>
<sub>1/2</sub> = 19.5 h suitable for therapeutic applications.<xref rid="ref16" ref-type="bibr"/>
</p><p>The coordination chemistry in aqueous
media of La<sup>3+</sup> and
the remaining lanthanide ions (Ln<sup>3+</sup>) is conditioned by
their hard acid character according to Pearson&#8217;s classification<named-content content-type="bibref-group">
<xref rid="ref17" ref-type="bibr"/>,<xref rid="ref18" ref-type="bibr"/>
</named-content> and their tendency to reach high coordination numbers, often 8&#8211;9.<named-content content-type="bibref-group">
<xref rid="ref19" ref-type="bibr"/>,<xref rid="ref20" ref-type="bibr"/>
</named-content> Stable complexation of the Ln<sup>3+</sup> is often achieved with
derivatives of macrocyclic chelator DOTA, which has dominated the
medical applications based on these metal ions.<named-content content-type="bibref-group">
<xref rid="ref21" ref-type="bibr"/>,<xref rid="ref22" ref-type="bibr"/>
</named-content> However, DOTA derivatives often experience slow complexation kinetics,
which pose some limitations for radiopharmaceutical development.<named-content content-type="bibref-group">
<xref rid="ref23" ref-type="bibr"/>,<xref rid="ref24" ref-type="bibr"/>
</named-content> Furthermore, La<sup>3+</sup> is the ion of the lanthanide series
with the largest ionic radius,<xref rid="ref25" ref-type="bibr"/> which
in some cases results in the formation of ten- or even 11-coordinate
complexes.<named-content content-type="bibref-group">
<xref rid="ref26" ref-type="bibr"/>&#8722;<xref rid="ref27" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref28" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref29" ref-type="bibr"/>
</named-content> As a result, hexadentate chelators such as H<sub>3</sub>NOTA and
DiAmSar are not well suited for lanthanide complexation. Enlarging
the cavity of H<sub>4</sub>DOTA to give H<sub>4</sub>TETA was also
found to be detrimental in terms of the stability of lanthanide complexes.<xref rid="ref30" ref-type="bibr"/> In addition, the Ac<sup>3+</sup> ion is the
largest among the trivalent metal ions of the periodic table (excluding
the transactinide elements). Thus, the development of theranostic
pairs based on La and Ac radioisotopes requires designing new chelators
with adequate properties. So far, macrocyclic chelators such as H<sub>2</sub>MACROPA, H<sub>4</sub>PYTA and H<sub>4</sub>DO3Apic have been
established as promising chelators for these radioisotopes, with H<sub>2</sub>MACROPA being considered the leading chelator for Ac<sup>3+</sup> complexation (<xref rid="cht1" ref-type="fig">Chart <xref rid="cht1" ref-type="fig"/>
</xref>).<named-content content-type="bibref-group">
<xref rid="ref1" ref-type="bibr"/>,<xref rid="ref27" ref-type="bibr"/>,<xref rid="ref31" ref-type="bibr"/>
</named-content> Nevertheless,
the nature of the chelating unit may have a large impact in the performance
of bifunctional chelators, and thus expanding the range of chelators
for the complexation of La<sup>3+</sup> is highly important for radiopharmaceutical
development. Given the huge commercial investment in theranostic agents
in nuclear medicine and oncology,<xref rid="ref32" ref-type="bibr"/> developing
new efficient chelators for La radioisotopes is key to successfully
support both therapeutic and diagnostic uses in precision medicine.</p><fig position="float" id="cht1" fig-type="chart" orientation="portrait"><label>1</label><caption><title>Chelators Discussed in This Work</title></caption><graphic id="gr1" position="float" orientation="portrait" xlink:href="jm5c01558_0001.jpg"/></fig><p>The octadentate acyclic ligand H<sub>4</sub>OCTAPA has been established
as an interesting candidate for the design of <sup>177</sup>Lu, <sup>90</sup>Y and <sup>111</sup>In radiopharmaceuticals.<named-content content-type="bibref-group">
<xref rid="ref33" ref-type="bibr"/>&#8722;<xref rid="ref34" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref35" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref36" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref37" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref38" ref-type="bibr"/>
</named-content> Furthermore, the lanthanide complexes of the rigidified derivative
H<sub>4</sub>
<italic toggle="yes">CHX</italic>OCTAPA were found to be considerably
more inert with respect to complex dissociation than the corresponding
complexes with H<sub>4</sub>OCTAPA.<named-content content-type="bibref-group">
<xref rid="ref39" ref-type="bibr"/>,<xref rid="ref40" ref-type="bibr"/>
</named-content> Considering
the large ionic radii of La<sup>3+</sup> and Ac<sup>3+</sup>, we sought
to modify these acyclic chelators to incorporate up to ten donor atoms.
This lead us to identify H<sub>4</sub>TPAEN, first reported by Mazzanti
for the formation of highly luminescent Eu<sup>3+</sup> and Tb<sup>3+</sup> complexes, as a potential candidate.<xref rid="ref41" ref-type="bibr"/> Furthermore, we envisaged that the rigidified H<sub>4</sub>TPADAC chelator could increase the inertness of the complexes, as
observed for H<sub>4</sub>OCTAPA derivatives of the small Ln<sup>3+</sup> ions (Gd<sup>3+</sup> and Lu<sup>3+</sup>).<named-content content-type="bibref-group">
<xref rid="ref39" ref-type="bibr"/>,<xref rid="ref40" ref-type="bibr"/>
</named-content> This chelator was recently described by Adewuyi et al. to prepare
circularly polarized Ln<sup>3+</sup> emitting complexes.<xref rid="ref42" ref-type="bibr"/> However, the coordination chemistry of La<sup>3+</sup> with H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC and their
potential for the development of radiopharmaceuticals remains unexplored.</p><p>Herein, we provide a detailed investigation on the coordination
chemistry of H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC with La<sup>3+</sup>, including a detailed structural study using NMR spectroscopy
and single-crystal X-ray diffraction. We also report a thermodynamic
study that afforded the stability constants of the complexes, as well
as an investigation of their dissociation kinetics. Finally, we present <sup>135</sup>La radiolabeling studies as well as <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> stability studies, which support further
development of these chelators for La<sup>3+</sup>-based radiopharmaceuticals.</p></sec><sec id="sec2"><title>Results
and Discussion</title><sec id="sec2.1"><title>Synthesis and Characterization of the Chelators</title><p>The
preparation of ligands H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC
was achieved by alkylation of the amine precursors with 6-(chloromethyl)&#173;picolinic
acid, using slight modifications of the literature procedures (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Scheme S1</ext-link>, Supporting Information).<named-content content-type="bibref-group">
<xref rid="ref41" ref-type="bibr"/>,<xref rid="ref42" ref-type="bibr"/>
</named-content>
</p><p>Ligand protonation constants were determined in 0.15 M NaCl
using potentiometric titrations (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figures S1&#8211;S2</ext-link>, Supporting Information). The results are compared with those reported
previously for OCTAPA<sup>4&#8211;</sup> and <italic toggle="yes">CHX</italic>OCTAPA<sup>4&#8211;</sup> in <xref rid="tbl1" ref-type="table">Table <xref rid="tbl1" ref-type="table"/>
</xref>, while the speciation diagrams are shown in <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S3</ext-link> (Supporting Information). The first
two protonation constants of these ligands, characterized by log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup> and log <italic toggle="yes">K</italic>
<sub>2</sub>
<sup>H</sup>, correspond to the protonation of amine groups,
while the remaining protonation constants are ascribed to the carboxylate
groups of picolinate and acetate moieties.<named-content content-type="bibref-group">
<xref rid="ref33" ref-type="bibr"/>,<xref rid="ref43" ref-type="bibr"/>,<xref rid="ref44" ref-type="bibr"/>
</named-content>
</p><table-wrap position="float" id="tbl1" orientation="portrait"><label>1</label><caption><title>Protonation Constants
of TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup> ligands
(<italic toggle="yes">I</italic> = 0.15 M NaCl, 25 &#176;C) and Values Reported
in the Literature
for Related Ligands</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="center" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">
<bold>TPAEN</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th><th align="center" colspan="1" rowspan="1">
<bold>TPADAC</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th><th align="center" colspan="1" rowspan="1">
<bold>OCTAPA</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th><th align="center" colspan="1" rowspan="1">
<italic toggle="yes">
<bold>CHX</bold>
</italic>
<bold>OCTAPA</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th><th align="center" char="." colspan="1" rowspan="1">
<bold>DTPA</bold>
<sup>
<bold>5&#8209;</bold>
</sup>
<xref rid="t1fn5" ref-type="table-fn"/>
</th><th align="center" char="." colspan="1" rowspan="1">
<bold>EDTA</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
<xref rid="t1fn6" ref-type="table-fn"/>
</th><th align="center" char="." colspan="1" rowspan="1">
<bold>CDTA</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
<xref rid="t1fn6" ref-type="table-fn"/>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup>
</td><td align="left" colspan="1" rowspan="1">7.87(1)</td><td align="left" colspan="1" rowspan="1">10.79(1)</td><td align="left" colspan="1" rowspan="1">8.52<xref rid="t1fn1" ref-type="table-fn"/>/8.58<xref rid="t1fn2" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">9.52<xref rid="t1fn3" ref-type="table-fn"/>/9.23<xref rid="t1fn4" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">9.93</td><td align="char" char="." colspan="1" rowspan="1">9.17</td><td align="char" char="." colspan="1" rowspan="1">9.36</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>2</sub>
<sup>H</sup>
</td><td align="left" colspan="1" rowspan="1">5.14(1)</td><td align="left" colspan="1" rowspan="1">4.95(1)</td><td align="left" colspan="1" rowspan="1">5.40<xref rid="t1fn1" ref-type="table-fn"/>/5.43<xref rid="t1fn2" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">5.51<xref rid="t1fn3" ref-type="table-fn"/>/5.40<xref rid="t1fn4" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">8.37</td><td align="char" char="." colspan="1" rowspan="1">5.99</td><td align="char" char="." colspan="1" rowspan="1">5.95</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>3</sub>
<sup>H</sup>
</td><td align="left" colspan="1" rowspan="1">3.89(1)</td><td align="left" colspan="1" rowspan="1">4.06(1)</td><td align="left" colspan="1" rowspan="1">3.65<xref rid="t1fn1" ref-type="table-fn"/>/3.75<xref rid="t1fn2" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">3.99<xref rid="t1fn3" ref-type="table-fn"/>/3.94<xref rid="t1fn4" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">4.18</td><td align="char" char="." colspan="1" rowspan="1">2.73</td><td align="char" char="." colspan="1" rowspan="1">3.62</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>4</sub>
<sup>H</sup>
</td><td align="left" colspan="1" rowspan="1">3.28(1)</td><td align="left" colspan="1" rowspan="1">3.46(1)</td><td align="left" colspan="1" rowspan="1">2.97<xref rid="t1fn1" ref-type="table-fn"/>/3.08<xref rid="t1fn2" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">3.43<xref rid="t1fn3" ref-type="table-fn"/>/2.24<xref rid="t1fn4" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">2.71</td><td align="char" char="." colspan="1" rowspan="1">2.01</td><td align="char" char="." colspan="1" rowspan="1">2.57</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>5</sub>
<sup>H</sup>
</td><td align="left" colspan="1" rowspan="1">2.55(1)</td><td align="left" colspan="1" rowspan="1">2.94(1)</td><td align="left" colspan="1" rowspan="1">1.66<xref rid="t1fn1" ref-type="table-fn"/>/2.21<xref rid="t1fn2" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">1.59<xref rid="t1fn3" ref-type="table-fn"/>/1.82<xref rid="t1fn4" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">2.00</td><td align="char" char="." colspan="1" rowspan="1">1.38</td><td align="char" char="." colspan="1" rowspan="1">1.49</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>6</sub>
<sup>H</sup>
</td><td align="left" colspan="1" rowspan="1">0.89(8)</td><td align="left" colspan="1" rowspan="1">0.67(6)</td><td align="left" colspan="1" rowspan="1">1.61<xref rid="t1fn2" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">0.61<xref rid="t1fn3" ref-type="table-fn"/>/1.91<xref rid="t1fn4" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">&#931;
log <italic toggle="yes">K</italic>
<sub>i</sub>
<sup>H</sup> (<italic toggle="yes">i</italic>&#160;=&#160;1&#8211;5)</td><td align="left" colspan="1" rowspan="1">22.73</td><td align="left" colspan="1" rowspan="1">26.20</td><td align="left" colspan="1" rowspan="1">22.20</td><td align="left" colspan="1" rowspan="1">24.04</td><td align="char" char="." colspan="1" rowspan="1">27.19</td><td align="char" char="." colspan="1" rowspan="1">21.27</td><td align="char" char="." colspan="1" rowspan="1">22.99</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Data from ref <xref rid="ref43" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t1fn2"><label>b</label><p>Data from ref <xref rid="ref33" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t1fn3"><label>c</label><p>Data from ref <xref rid="ref40" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t1fn4"><label>d</label><p>Data
from ref <xref rid="ref34" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t1fn5"><label>e</label><p>Data from ref <xref rid="ref50" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t1fn6"><label>f</label><p>Data from ref <xref rid="ref51" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn></table-wrap-foot></table-wrap><p>This
series of ligands present significant differences in the values
of the first protonation constant log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup>, which involves one of the amine N atoms. The replacement
of acetate groups of EDTA<sup>4&#8211;</sup> by picolinate pendant
arms provokes a decrease of log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup>, an effect that has been attributed to the stronger electron
withdrawing effect of the picolinate units compared with acetate groups.<xref rid="ref44" ref-type="bibr"/> Thus, the log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup> values follow the order EDTA<sup>4&#8211;</sup> &gt;
OCTAPA<sup>4&#8211;</sup> &gt; TPAEN<sup>4&#8211;</sup>. A comparison
of the
first protonation constants reported for EDTA<sup>4&#8211;</sup> and
CDTA<sup>4&#8211;</sup> indicates that the cyclohexyl derivative
possesses a slightly higher log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup> value (&#916;log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup> = 0.19), which can be attributed to the inductive effect of the
added alkyl groups.<xref rid="ref45" ref-type="bibr"/> This effect is more
pronounced (&#916;log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup> =
&#8764;1.0) when comparing OCTAPA<sup>4&#8211;</sup> with its cyclohexyl
analogue, and then increases dramatically for the decadentate derivatives
(&#916;log <italic toggle="yes">K</italic>
<sub>1</sub>
<sup>H</sup> = 2.9). However,
all remaining protonation constants determined for TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup> are rather similar. This suggests
that the monoprotonated form of TPADAC<sup>4&#8211;</sup> is very
likely stabilized by intramolecular hydrogen bonds involving the protonated
amine N atom and heteroatoms of the picolinate groups. The second
protonation constant of both chelators, characterized by log <italic toggle="yes">K</italic>
<sub>2</sub>
<sup>H</sup>, can be attributed to the protonation
of the second amine nitrogen atom, while the remaining protonation
processes involve the carboxylate groups of the picolinate units.
This is confirmed by the X-ray structure of [H<sub>5</sub>TPAEN]&#173;Cl&#183;3H<sub>2</sub>O, which evidence protonation of the amine N atoms and three
carboxylate groups (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig"/>
</xref>). A rather intricate network of hydrogen bonds involves the
amine NH groups, carboxylate groups, water molecules and chloride
anions.</p><fig position="float" id="fig1" fig-type="figure" orientation="portrait"><label>1</label><caption><p>X-ray crystal structure of [H<sub>5</sub>TPAEN]&#173;Cl&#183;3H<sub>2</sub>O plotted with ellipsoids at the 50% probability level. Hydrogen
atoms bonded to C atoms are omitted for simplicity.</p></caption><graphic id="gr2" position="float" orientation="portrait" xlink:href="jm5c01558_0002.jpg"/></fig><p>The <sup>1</sup>H and <sup>13</sup>C NMR spectra of H<sub>4</sub>TPAEN recorded at acidic pH (pD = 2.8) are well-defined, displaying
five and eight signals, respectively (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figures S4&#8211;S9</ext-link>, Supporting Information). In contrast, the <sup>1</sup>H and <sup>13</sup>C NMR spectra recorded for H<sub>4</sub>TPADAC at 298 K (pD = 2.2) display broad signals characteristic of
fluxional behavior (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figures S10&#8211;S17</ext-link>, Supporting Information). The <sup>13</sup>C NMR spectrum recorded
at 278 K displays duplicate signals for the picolinate groups, pointing
to a <italic toggle="yes">C</italic>
<sub>2</sub> symmetry of the ligand in which
picolinate groups are equivalent in pairs (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>). These signals broaden on increasing temperature,
reach coalescence and finally become sharp at 338 K once the fast
exchange regime is reached. At high temperature the <sup>13</sup>C
NMR spectrum displays 10 signals, with the four picolinate groups
being equivalent. This suggests that the presence of intramolecular
hydrogen bonds and the rigidity of the cyclohexyl spacer introduces
a significant energy barrier for the inversion of the amine N atoms.<named-content content-type="bibref-group">
<xref rid="ref46" ref-type="bibr"/>&#8722;<xref rid="ref47" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref48" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref49" ref-type="bibr"/>
</named-content> This is confirmed by the <sup>1</sup>H NMR spectrum recorded at
high pH (pD = 12.8), in which the four picolinate units are magnetically
equivalent (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S16</ext-link>, Supporting Information).</p><fig position="float" id="fig2" fig-type="figure" orientation="portrait"><label>2</label><caption><p>
<sup>13</sup>C NMR spectra recorded for H<sub>4</sub>TPADAC in
D<sub>2</sub>O solution (pD = 2.2, 100.6 MHz) at different temperatures.
The inset shows the line width analysis of the resonances of the methylenic
protons of the picolinate groups and the fits of the data to determine
the rate constants (<italic toggle="yes">k</italic>
<sub>ex</sub>) for the amine
interconversion process. The asterisk denotes signals due to residual
trifluoroacetic acid.</p></caption><graphic id="gr3" position="float" orientation="portrait" xlink:href="jm5c01558_0003.jpg"/></fig><p>The two signals observed
for the methylenic protons of the picolinate
groups are observed at 52.0 and 55.9 ppm at 278 K and pD 2.2. The
dynamic process observed for these signals is a simple interconversion
between two sites with equal populations. Thus, rate constants for
amine N atom inversion were obtained by line width analysis in the
temperature range 278&#8211;338 K (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig"/>
</xref>). The rate constants were subsequently used
to determine the activation parameters for the interconversion process
using an Eyring plot (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S18</ext-link>, Supporting
Information). This analysis afforded values of the enthalpy and entropy
of activation of &#916;<italic toggle="yes">H</italic>
<sup>&#8225;</sup> = 33.8
&#177; 2.8 kJ mol<sup>&#8211;1</sup> and &#916;<italic toggle="yes">S</italic>
<sup>&#8225;</sup> = &#8722;83.8 &#177; 6.7 J mol<sup>&#8211;1</sup> K<sup>&#8211;1</sup>, which indicates that the interconversion
process has a significant entropy barrier. The activation free energy
at 298.15 K and the rate constant at this temperature take values
of &#916;<italic toggle="yes">G</italic>
<sub>298</sub>
<sup>&#8225;</sup> = 58.8
&#177; 3.4 kJ mol<sup>&#8211;1</sup> and <italic toggle="yes">k</italic>
<sub>ex</sub>
<sup>298</sup> = 310 &#177; 18 s<sup>&#8211;1</sup>, respectively.</p></sec><sec id="sec2.2"><title>Structural Characterization of the Complexes</title><p>The structures
of the La<sup>3+</sup> complexes were investigated using single crystal
X-ray diffraction measurements. Single crystals with formula [La&#173;(HTPAEN)]&#183;12H<sub>2</sub>O were grown from a solution of the complex in methanol (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig"/>
</xref>). Crystals with
formula [LaCl&#173;(H<sub>2</sub>O)<sub>3</sub>]&#173;[La&#173;(TPADAC)]&#173;Cl&#183;3H<sub>2</sub>O were obtained from an aqueous solution of the complex containing
excess La<sup>3+</sup>. They contain the [La&#173;(TPADAC)]<sup>&#8722;</sup> complex and La<sup>3+</sup> ions coordinated to three water molecules,
a chloride anion and four oxygen atoms of carboxylate groups of four
[La&#173;(TPADAC)]<sup>&#8722;</sup> entities (see <xref rid="fig3" ref-type="fig">Figures <xref rid="fig3" ref-type="fig"/>
</xref> and <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">S20</ext-link>, Supporting
Information).</p><fig position="float" id="fig3" fig-type="figure" orientation="portrait"><label>3</label><caption><p>Views of the X-ray structures of the [La&#173;(HTPAEN)] (top)
and [La&#173;(TPADAC)]<sup>&#8722;</sup> (bottom) complexes with ellipsoids
plotted at the
50% probability level.</p></caption><graphic id="gr4" position="float" orientation="portrait" xlink:href="jm5c01558_0004.jpg"/></fig><p>The La<sup>3+</sup> ions
in both [La&#173;(HTPAEN)] and [La&#173;(TPADAC)]<sup>&#8722;</sup> complexes
are directly coordinated to the ten donor
atoms of the ligand, which in the former is protonated on one of the
carboxylate groups. The four picolinate groups of the ligand wrap
around the pseudo <italic toggle="yes">C</italic>
<sub>2</sub> axis that contains
the La<sup>3+</sup> ion and bisects the C&#58872;C bond of the central
ethylenediamine (or cyclohexyldiamine) spacer, giving rise to two
possible helical forms that are often denoted as &#916; and &#923;.<xref rid="ref52" ref-type="bibr"/> The &#916; <italic toggle="yes">c</italic>onfiguration is
associated with positive values of the four N&#58872;C&#58872;C&#58872;N
dihedral angles involving the picolinate groups, while negative values
indicate a &#923; configuration.<xref rid="ref53" ref-type="bibr"/> Furthermore,
the formation of the five-membered chelate ring upon coordination
of the two amine N atoms generates a second source of helicity, which
can be described as &#948; or &#955;.<xref rid="ref54" ref-type="bibr"/> The [La&#173;(HTPAEN)] complex crystallizes in the centrosymmetric <italic toggle="yes">P&#773;</italic>1 triclinic space group, and thus the &#916;&#173;(&#955;)
and &#923;&#173;(&#948;) enantiomers are present in the crystal lattice
related by an inversion center. Compound [LaCl&#173;(H<sub>2</sub>O)<sub>3</sub>]&#173;[La&#173;(TPADAC)]&#173;Cl&#183;3H<sub>2</sub>O crystallizes in the chiral
monoclinic <italic toggle="yes">P</italic>2<sub>1</sub> space group, and thus only
the &#916;&#173;(&#955;) enantiomer is present in the crystal lattice,
a situation imposed by the use of the enantiomerically pure (1<italic toggle="yes">R</italic>,2<italic toggle="yes">R</italic>)-cyclohexane-1,2-diamine precursor
for the ligand synthesis.</p><p>The bond distances of the La<sup>3+</sup> coordination environments
in the [La&#173;(HTPAEN)] and [La&#173;(TPADAC)]<sup>&#8722;</sup> complexes
are presented in <xref rid="tbl2" ref-type="table">Table <xref rid="tbl2" ref-type="table"/>
</xref>. The number of X-ray structures reported for La<sup>3+</sup> complexes
with picolinate ligands is rather scarce,<named-content content-type="bibref-group">
<xref rid="ref27" ref-type="bibr"/>,<xref rid="ref55" ref-type="bibr"/>,<xref rid="ref56" ref-type="bibr"/>
</named-content> with very few structures containing ten-coordinated
La<sup>3+</sup> ions.<named-content content-type="bibref-group">
<xref rid="ref26" ref-type="bibr"/>,<xref rid="ref57" ref-type="bibr"/>
</named-content> Thus, we analyzed the bond distances
of the La<sup>3+</sup> coordination environments by estimating standard
values using the crystal radius of La<sup>3+</sup> for coordination
number ten (CR<sub>La</sub> = 1.41 &#197;)<xref rid="ref58" ref-type="bibr"/> and the donor radii reported recently for the rare earths (<italic toggle="yes">r</italic>
<sub>D</sub>).<xref rid="ref59" ref-type="bibr"/> This provides
reference values calculated as <italic toggle="yes">r</italic>
<sub>D</sub> + CR<sub>La</sub> that can be used to compare with experimental data. The
differences between experimental and reference values (&#916;<italic toggle="yes">d</italic>) obtained for [La&#173;(HTPAEN)] are small, with absolute values
being &lt;0.05 &#197; for all donor atoms except O(3), which involves
a protonated carboxylate group. The situation is very different for
[La&#173;(TPADAC)]<sup>&#8722;</sup>, which shows large positive values
for the amine N atoms. This indicates that the TPAEN<sup>4&#8211;</sup> ligand is better suited to adapt to the coordination requirements
of the La<sup>3+</sup> ion than TPADAC<sup>4&#8211;</sup>, a situation
that appears to be related to the smaller bite distance (N(2)&#183;&#183;&#183;N(3)
= 2.972 &#197;) and bite angle (N(2)&#58872;La(1)&#58872;N(3) = 60.48(13)&#176;)
of the central chelate ring in [La&#173;(TPADAC)]<sup>&#8722;</sup> when
compared with [La&#173;(HTPAEN)] (N(2)&#183;&#183;&#183;N(3) = 3.002 &#197;;
N(2)&#58872;La(1)&#58872;N(3) = 63.16(9)&#176;).</p><table-wrap position="float" id="tbl2" orientation="portrait"><label>2</label><caption><title>Bond Distances (&#197;) of the La<sup>3+</sup> Coordination Environments
in the X-ray Structures of [La&#173;(HTPAEN)]
and [La&#173;(TPADAC)]<sup>&#8722;</sup> (<italic toggle="yes">d</italic>
<sub>La&#8209;D</sub>) Compared with Those Estimated from Donor Radii and Crystal Radii
(<italic toggle="yes">r</italic>
<sub>D</sub> + CR<sub>La</sub>) and the Differences
between Them &#916;<italic toggle="yes">d</italic>
</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="center" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">&#160;</th><th colspan="2" align="center" char="." rowspan="1">
<italic toggle="yes">d</italic>
<sub>La&#8209;D</sub>
<hr/></th><th align="center" char="." colspan="1" rowspan="1">&#160;</th><th colspan="2" align="center" char="." rowspan="1">&#916;<italic toggle="yes">d</italic>
<xref rid="t2fn1" ref-type="table-fn"/>
<hr/></th></tr><tr><th align="center" colspan="1" rowspan="1">donor type</th><th align="center" colspan="1" rowspan="1">&#160;</th><th align="center" char="." colspan="1" rowspan="1">TPAEN</th><th align="center" char="." colspan="1" rowspan="1">TPADAC</th><th align="center" char="." colspan="1" rowspan="1">
<italic toggle="yes">r</italic>
<sub>D</sub> + CR<sub>La</sub>
</th><th align="center" char="." colspan="1" rowspan="1">TPAEN</th><th align="center" char="." colspan="1" rowspan="1">TPADAC</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">carboxylate</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;O(1)</td><td align="char" char="." colspan="1" rowspan="1">2.498(3)</td><td align="char" char="." colspan="1" rowspan="1">2.552(4)</td><td align="char" char="." colspan="1" rowspan="1">2.542</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.044</td><td align="char" char="." colspan="1" rowspan="1">0.010</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;O(3)</td><td align="char" char="." colspan="1" rowspan="1">2.617(3)</td><td align="char" char="." colspan="1" rowspan="1">2.532(4)</td><td align="char" char="." colspan="1" rowspan="1">2.542</td><td align="char" char="." colspan="1" rowspan="1">0.075</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.010</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;O(5)</td><td align="char" char="." colspan="1" rowspan="1">2.547(3)</td><td align="char" char="." colspan="1" rowspan="1">2.518(4)</td><td align="char" char="." colspan="1" rowspan="1">2.542</td><td align="char" char="." colspan="1" rowspan="1">0.005</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.024</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;O(7)</td><td align="char" char="." colspan="1" rowspan="1">2.537(3)</td><td align="char" char="." colspan="1" rowspan="1">2.488(4)</td><td align="char" char="." colspan="1" rowspan="1">2.542</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.005</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.054</td></tr><tr><td align="left" colspan="1" rowspan="1">amine</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;N(2)</td><td align="char" char="." colspan="1" rowspan="1">2.854(3)</td><td align="char" char="." colspan="1" rowspan="1">2.968(5)</td><td align="char" char="." colspan="1" rowspan="1">2.835</td><td align="char" char="." colspan="1" rowspan="1">0.019</td><td align="char" char="." colspan="1" rowspan="1">0.133</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;N(3)</td><td align="char" char="." colspan="1" rowspan="1">2.878(3)</td><td align="char" char="." colspan="1" rowspan="1">2.933(4)</td><td align="char" char="." colspan="1" rowspan="1">2.835</td><td align="char" char="." colspan="1" rowspan="1">0.043</td><td align="char" char="." colspan="1" rowspan="1">0.098</td></tr><tr><td align="left" colspan="1" rowspan="1">pyridine</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;N(1)</td><td align="char" char="." colspan="1" rowspan="1">2.694(3)</td><td align="char" char="." colspan="1" rowspan="1">2.699(5)</td><td align="char" char="." colspan="1" rowspan="1">2.739</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.045</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.040</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;N(4)</td><td align="char" char="." colspan="1" rowspan="1">2.770(3)</td><td align="char" char="." colspan="1" rowspan="1">2.722(5)</td><td align="char" char="." colspan="1" rowspan="1">2.739</td><td align="char" char="." colspan="1" rowspan="1">0.031</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.017</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;N(5)</td><td align="char" char="." colspan="1" rowspan="1">2.734(3)</td><td align="char" char="." colspan="1" rowspan="1">2.708(5)</td><td align="char" char="." colspan="1" rowspan="1">2.739</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.005</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.031</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160;</td><td align="left" colspan="1" rowspan="1">La(1)&#58872;N(6)</td><td align="char" char="." colspan="1" rowspan="1">2.701(3)</td><td align="char" char="." colspan="1" rowspan="1">2.691(5)</td><td align="char" char="." colspan="1" rowspan="1">2.739</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.038</td><td align="char" char="." colspan="1" rowspan="1">&#8211;0.048</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>&#916;<italic toggle="yes">d</italic> = <italic toggle="yes">d</italic>
<sub>La&#8209;D</sub> &#8211; (<italic toggle="yes">r</italic>
<sub>D</sub> + CR<sub>La</sub>), and
thus negative values indicate that
the observed distances (<italic toggle="yes">d</italic>
<sub>La&#8209;D</sub>)
are shorter than the reference values (<italic toggle="yes">r</italic>
<sub>D</sub> + CR<sub>La</sub>).</p></fn></table-wrap-foot></table-wrap><p>The
five-membered chelate rings formed upon coordination of the
pyridine groups in rare-earth complexes display dihedral angles N&#58872;C&#58872;C&#58872;N
with ideal values of 32.0&#176;.<xref rid="ref60" ref-type="bibr"/> The
[La&#173;(HTPAEN)] complex shows dihedral angles that are relatively close
to the ideal value (30.7, 32.6, 24.7 and 35.8&#176;), while rather
large deviations are observed in [La&#173;(TPADAC)]<sup>&#8722;</sup> for
two of the dihedral angles (46.3 and 43.2&#176;). This again suggests
that the ethylenediamine spacer is better suited for La<sup>3+</sup> coordination than the rigid cyclohexane-1,2-diamine unit.</p><p>The structure of the [La&#173;(TPAEN)]<sup>&#8722;</sup> and [La&#173;(TPADAC)]<sup>&#8722;</sup> complexes in solution was investigated using <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figures S21&#8211;S29</ext-link>, Supporting Information). The <sup>1</sup>H NMR spectrum of [La&#173;(TPAEN)]<sup>&#8722;</sup> displays
12 signals, a situation that is consistent with an effective <italic toggle="yes">C</italic>
<sub>2</sub> symmetry of the complex in solution (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig"/>
</xref>). This is confirmed
by the <sup>13</sup>C NMR spectrum, which displays 15 signals for
the 30 carbon nuclei of the ligand backbone. Both the <sup>1</sup>H and <sup>13</sup>C NMR spectra are well resolved, with the methylene
protons observed as AB spin systems. This indicates that the complex
is rather rigid in solution, with a single diastereoisomer being present.
The <sup>1</sup>H NMR spectrum recorded for [La&#173;(TPADAC)]<sup>&#8722;</sup> is also consistent with a <italic toggle="yes">C</italic>
<sub>2</sub> symmetry,
although some broadening is observed. The full assignment of the <sup>1</sup>H and <sup>13</sup>C NMR spectra is presented in the Supporting
Information (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Tables S3&#8211;S4</ext-link>, Supporting
Information).</p><fig position="float" id="fig4" fig-type="figure" orientation="portrait"><label>4</label><caption><p>
<sup>1</sup>H NMR spectra (500 MHz) of the H<sub>4</sub>TPAEN (pD
= 7.4) and H<sub>4</sub>TPADAC (pD = 7.8) and their La<sup>3+</sup> complexes recorded in D<sub>2</sub>O solution at 298 K. The asterisk
denotes residual methanol.</p></caption><graphic id="gr5" position="float" orientation="portrait" xlink:href="jm5c01558_0005.jpg"/></fig></sec><sec id="sec2.3"><title>Stability Constants</title><p>The stability constants of the
La<sup>3+</sup> complexes were determined using pH potentiometry (<italic toggle="yes">I</italic> = 0.15 NaCl). A significant amount of the metal ion is
not complexed by the TPADAC<sup>4&#8211;</sup> ligand at the beginning
of the titration at pH 1.7 (&#8764;20%), which allows for stability
constant determination using potentiometry. In the case of TPAEN<sup>4&#8211;</sup> the amount of free La<sup>3+</sup> was small (&#8764;4%),
but the stability constants could be determined by fitting the titration
data using both 1:1 and 1:2 (TPAEN<sup>4&#8211;</sup>:La<sup>3+</sup>) stoichiometries (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S1</ext-link>, Supporting
Information). The TPADAC<sup>4&#8211;</sup> ligand also forms complexes
with 1:1 and 1:2 stoichiometries (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S2</ext-link>, Supporting Information). The fits of the titration curves improved
significantly by including a protonated form of the complexes and
a hydroxo-complex in the equilibrium model. The fits of the potentiometric
data afforded the equilibrium constants reported in <xref rid="tbl3" ref-type="table">Table <xref rid="tbl3" ref-type="table"/>
</xref>.</p><table-wrap position="float" id="tbl3" orientation="portrait"><label>3</label><caption><title>Stability
Constants of the La<sup>3+</sup> Complexes with TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup> (<italic toggle="yes">I</italic> = 0.15 M NaCl,
25 &#176;C) and
Values Reported in the Literature for Related Ligands</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="center" colspan="1" rowspan="1">&#160;</th><th align="center" char="." colspan="1" rowspan="1">
<bold>TPAEN</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th><th align="center" char="." colspan="1" rowspan="1">
<bold>TPADAC</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th><th align="center" colspan="1" rowspan="1">
<bold>OCTAPA</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
<xref rid="t3fn1" ref-type="table-fn"/>
</th><th align="center" char="." colspan="1" rowspan="1">
<italic toggle="yes">
<bold>CHX</bold>
</italic>
<bold>OCTAPA</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
<xref rid="t3fn2" ref-type="table-fn"/>
</th><th align="center" char="." colspan="1" rowspan="1">
<bold>DTPA</bold>
<xref rid="t3fn3" ref-type="table-fn"/>
</th><th align="center" char="." colspan="1" rowspan="1">
<bold>MACROPA</bold>
<sup>
<bold>2&#8209;</bold>
</sup>
</th><th align="center" char="." colspan="1" rowspan="1">
<bold>DO3Apic</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
<xref rid="t3fn6" ref-type="table-fn"/>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>LaL</sub>
</td><td align="char" char="." colspan="1" rowspan="1">19.16(8)</td><td align="char" char="." colspan="1" rowspan="1">19.55(1)</td><td align="left" colspan="1" rowspan="1">19.92</td><td align="char" char="." colspan="1" rowspan="1">17.82</td><td align="char" char="." colspan="1" rowspan="1">19.36</td><td align="char" char="." colspan="1" rowspan="1">14.99;<xref rid="t3fn4" ref-type="table-fn"/> 13.9<xref rid="t3fn5" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">21.17</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>LaL</sub>
<sup>H</sup>
</td><td align="char" char="." colspan="1" rowspan="1">2.02(9)</td><td align="char" char="." colspan="1" rowspan="1">2.26(1)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">2.00</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">2.28<xref rid="t3fn4" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">2.55</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>LaL</sub>
<sup>OH</sup>
</td><td align="char" char="." colspan="1" rowspan="1">12.62(9)</td><td align="char" char="." colspan="1" rowspan="1">12.06(1)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">12.75</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>LaL</sub>
<sup>La</sup>
</td><td align="char" char="." colspan="1" rowspan="1">2.31(13)</td><td align="char" char="." colspan="1" rowspan="1">2.85(1)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>La<sub>2</sub>L</sub>
<sup>OH</sup>
</td><td align="char" char="." colspan="1" rowspan="1">6.80(10)</td><td align="char" char="." colspan="1" rowspan="1">6.99(4)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">log <italic toggle="yes">K</italic>
<sub>La<sub>2</sub>LOH</sub>
<sup>OH</sup>
</td><td align="char" char="." colspan="1" rowspan="1">9.57(10)</td><td align="char" char="." colspan="1" rowspan="1">9.40(4)</td><td align="left" colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td><td align="char" char="." colspan="1" rowspan="1">&#160;</td></tr><tr><td align="left" colspan="1" rowspan="1">pLa<xref rid="t3fn7" ref-type="table-fn"/>
</td><td align="char" char="." colspan="1" rowspan="1">19.5</td><td align="char" char="." colspan="1" rowspan="1">17.1</td><td align="left" colspan="1" rowspan="1">19.7</td><td align="char" char="." colspan="1" rowspan="1">16.6</td><td align="char" char="." colspan="1" rowspan="1">16.2</td><td align="char" char="." colspan="1" rowspan="1">15.6</td><td align="char" char="." colspan="1" rowspan="1">16.6</td></tr></tbody></table><table-wrap-foot><fn id="t3fn1"><label>a</label><p>Data in 0.15 M
NaCl from ref <xref rid="ref43" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t3fn2"><label>b</label><p>Data in 0.15 M NaCl from ref <xref rid="ref39" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t3fn3"><label>c</label><p>Data in 0.1 M Na&#173;(ClO<sub>4</sub>) from ref <xref rid="ref62" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t3fn4"><label>d</label><p>Data in 0.1 M KCl from ref<xref rid="ref64" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t3fn5"><label>e</label><p>Data in 0.1 M NaCl from ref <xref rid="ref65" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t3fn6"><label>f</label><p>Data in 0.1 M KCl from ref <xref rid="ref63" ref-type="bibr" specific-use="ref-style=base-text"/>.</p></fn><fn id="t3fn7"><label>g</label><p>Calculated as &#8722;log&#173;[La<sup>3+</sup>]<sub>free</sub> for [L] = 10 &#956;M and [La<sup>3+</sup>] = 1 &#956;M
at pH 7.4 and 25 &#176;C.</p></fn></table-wrap-foot></table-wrap><p>The speciation diagrams obtained using the equilibrium data indicate
that the dissociation of the complex with TPAEN<sup>4&#8211;</sup> occurs at slightly lower pH (&lt;&#8764;2.5) than that of TPADAC<sup>4&#8211;</sup> (&lt;&#8764;3.0). Hydroxo-complex formation takes
place at rather high pH (&gt;9.0) in both cases, with the negatively
charged [La&#173;(TPAEN)]<sup>&#8722;</sup> and [La&#173;(TPADAC)]<sup>&#8722;</sup> complexes being the only species present in solution around physiological
pH values (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig"/>
</xref>). As mentioned above, the TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup> ligands form weak 1:2 L:La<sup>3+</sup> complex species
that are characterized by the equilibrium constants shown in <xref rid="tbl3" ref-type="table">Table <xref rid="tbl3" ref-type="table"/>
</xref>. Additional speciation
diagrams for a 1:2 (L:La<sup>3+</sup>) stoichiometry are shown in <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S30</ext-link> (Supporting Information). The formation
of these 1:2 L:La<sup>3+</sup> complexes is likely related to the
presence of bridging carboxylate units that connect La<sup>3+</sup> ions inside and outside the cage of the ligand, as observed for
phosphonate derivatives.<xref rid="ref61" ref-type="bibr"/>
</p><fig position="float" id="fig5" fig-type="figure" orientation="portrait"><label>5</label><caption><p>Speciation diagrams of
the La<sup>3+</sup>:TPAEN<sup>4&#8211;</sup> (left) and La<sup>3+</sup>:TPADAC<sup>4&#8211;</sup> (right) systems,
calculated for c<sub>La3+</sub> = c<sub>Lig</sub> = 10<sup>&#8211;3</sup> M (<italic toggle="yes">I</italic> = 0.15 M NaCl, 25 &#176;C).</p></caption><graphic id="gr6" position="float" orientation="portrait" xlink:href="jm5c01558_0006.jpg"/></fig><p>The stability constants (log <italic toggle="yes">K</italic>
<sub>LaL</sub>)
determined for the La<sup>3+</sup> complexes of TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup> are comparable to those reported
for OCTAPA<sup>4&#8211;</sup>,<xref rid="ref43" ref-type="bibr"/> DTPA<sup>5&#8211;</sup>
<xref rid="ref62" ref-type="bibr"/> and DO3Apic<sup>4&#8211;</sup>
<xref rid="ref63" ref-type="bibr"/> and significantly higher than that
of MACROPA<sup>2&#8211;</sup> (<xref rid="tbl3" ref-type="table">Table <xref rid="tbl3" ref-type="table"/>
</xref>).<xref rid="ref64" ref-type="bibr"/> The log <italic toggle="yes">K</italic>
<sub>LaL</sub> value determined for TPADAC<sup>4&#8211;</sup> is
also significantly higher than that reported previously for <italic toggle="yes">CHX</italic>OCTAPA<sup>4&#8211;</sup>, while those of TPAEN<sup>4&#8211;</sup> and OCTAPA<sup>4&#8211;</sup> are very similar.
Thus, increasing the denticity of the ligand in the cyclohexyl derivatives
leads to a considerably improvement of the stability constant. This
effect appears to be related to a poor fit of the &#8220;bite&#8221;
of the 1,2-cyclohexyldiamine unit and the large La<sup>3+</sup> ion
(see above). The complexes of TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup> form protonated complex species at low pH due to
the protonation of a picolinate group (log <italic toggle="yes">K</italic>
<sub>LaL</sub>
<sup>H</sup> &#8764; 2), as evidenced by the X-ray structure
of [La&#173;(HTPAEN)] described above. Protonated forms characterized by
similar protonation constants were also detected in the case of picolinate
derivatives <italic toggle="yes">CHX</italic>OCTAPA<sup>4&#8211;</sup>, MACROPA<sup>2&#8211;</sup> and DO3Apic<sup>4&#8211;</sup>. The complexes of
TPAEN<sup>4&#8211;</sup> and TPADAC<sup>4&#8211;</sup>, as well
as that of <italic toggle="yes">CHX</italic>OCTAPA<sup>4&#8211;</sup>, form hydroxo-complexes
at high pH (pH &gt; 10.5 and 9.5, respectively).</p><p>The thermodynamic
stability of the complexes at physiologically
relevant pH was assessed by calculating pLa values, defined as &#8722;log&#173;[La<sup>3+</sup>]<sub>free</sub> for [L] = 10 &#956;M and [La<sup>3+</sup>] = 1 &#956;M at pH 7.4 and 25 &#176;C following the recommendation
of Raymond.<xref rid="ref66" ref-type="bibr"/> TPAEN<sup>4&#8211;</sup> and OCTAPA<sup>4&#8211;</sup> display the highest pLa values among
the ligands listed in <xref rid="tbl3" ref-type="table">Table <xref rid="tbl3" ref-type="table"/>
</xref>. This is a result of the high stability constants (log <italic toggle="yes">K</italic>
<sub>LaL</sub>) that characterize the formation of these
complexes, as well as the relatively low basicity of these ligands.
Indeed, cyclohexyl derivatives TPADAC<sup>4&#8211;</sup> and <italic toggle="yes">CHX</italic>OCTAPA<sup>4&#8211;</sup> display considerably higher
basicity than the ethyl analogues, as indicated by the &#931; log <italic toggle="yes">K</italic>
<sub>i</sub>
<sup>H</sup> (<italic toggle="yes">i</italic> = 1&#8211;5)
values shown in <xref rid="tbl1" ref-type="table">Table <xref rid="tbl1" ref-type="table"/>
</xref>. Similarly, DTPA and DO3A derivatives are characterized by rather
high basicities, which results in relatively low pLa values.<xref rid="ref50" ref-type="bibr"/>
</p></sec><sec id="sec2.4"><title>Dissociation Kinetics</title><p>The inertness
of metal complexes
for radiopharmaceutical applications is important to ensure that the
radioisotope is not released <italic toggle="yes">in vivo</italic> off-target.
Furthermore, the detailed study of the dissociation mechanism of the
complexes provides useful information for ligand design. Thus, we
performed a detailed investigation of the dissociation kinetics of
the [La&#173;(TPAEN)]<sup>&#8722;</sup> and [La&#173;(TPADAC)]<sup>&#8722;</sup> complexes using Cu<sup>2+</sup> as a scavenger. The reactions were
studied spectrophotometrically in the approximate proton concentration
range 1.1 &#215; 10<sup>&#8211;5</sup>&#8211;1.6 &#215; 10<sup>&#8211;2</sup> M, which corresponds to a pH range of about 1.8&#8211;5.0. A large
excess of Cu<sup>2+</sup> was used to ensure pseudo-first order conditions.
The observed rate constants (<italic toggle="yes">k</italic>
<sub>obs</sub>) are
shown in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig"/>
</xref>.</p><fig position="float" id="fig6" fig-type="figure" orientation="portrait"><label>6</label><caption><p>Pseudo-first
order rate constants (<italic toggle="yes">k</italic>
<sub>obs</sub>) obtained for
the transmetalation reactions with Cu<sup>2+</sup> of (a) [La&#173;(TPAEN)]<sup>&#8722;</sup> and (b) [La&#173;(TPADAC)]<sup>&#8722;</sup> as a function
of the concentration of H<sup>+</sup> ions (25 &#176;C,
0.15 M NaCl, c<sub>LaL</sub> = 0.25 mM, c<sub>Cu2+</sub> = 2.98 mM
(12&#215;); 5.52 mM (22&#215;), 7.98 mM (32&#215;) and 10.52 mM (42&#215;)).
Insets: zoom of the proton concentration range 0&#8211;4.5 &#215;
10<sup>&#8211;4</sup> M. The solid lines represent the fits of the
data (<italic toggle="yes">R</italic>
<sup>2</sup> &gt; 0.996).</p></caption><graphic id="gr7" position="float" orientation="portrait" xlink:href="jm5c01558_0007.jpg"/></fig><p>The values of <italic toggle="yes">k</italic>
<sub>obs</sub> increase with increasing
Cu<sup>2+</sup> concentration in a proton concentration range of 1.1
&#215; 10<sup>&#8211;5</sup>&#8211;3.7 &#215; 10<sup>&#8211;4</sup> M, indicating that the metal-assisted pathway, through the formation
of a heterodinuclear (LaLCu) complex, contributes to the dissociation
of the complexes characterized by rate constant <italic toggle="yes">k</italic>
<sub>3</sub>
<sup>Cu</sup>. Furthermore, the values of <italic toggle="yes">k</italic>
<sub>obs</sub> increase with decreasing [H<sup>+</sup>] below &#8764;0.1
mM (see insets in <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig"/>
</xref>), indicating that complex dissociation also occurs through
the formation of a dinuclear hydroxo-complex, characterized by <italic toggle="yes">k</italic>
<sub>6</sub>
<sup>Cu</sup>. The dissociation rates increase
with H<sup>+</sup> concentration for [H<sup>+</sup>] &gt; 0.1 mM,
indicating
dissociation through the proton-assisted pathway. The latter may proceed
through the formation of mono- or diprotonated intermediates, with
associated rate constants <italic toggle="yes">k</italic>
<sub>1</sub> and <italic toggle="yes">k</italic>
<sub>2</sub>, respectively. The dissociation rates obtained
under these conditions evidence a quadratic dependence on [H<sup>+</sup>], indicating that both <italic toggle="yes">k</italic>
<sub>1</sub> and <italic toggle="yes">k</italic>
<sub>2</sub> contribute significantly to the overall dissociation
rates. We have recently observed a similar behavior for the [Lu&#173;(<italic toggle="yes">CHX</italic>OCTAPA)]<sup>&#8722;</sup> complex.<xref rid="ref39" ref-type="bibr"/> Thus, we analyzed the kinetic data using the following
expression:<disp-formula id="eq1"><label>1</label><alternatives><graphic position="float" orientation="portrait" xlink:href="jm5c01558_m001.jpg"/><mml:math id="d1e2437" display="block"><mml:msub><mml:mi>k</mml:mi><mml:mi>obs</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mi mathvariant="normal">H</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mi mathvariant="normal">H</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mi>Cu</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>6</mml:mn></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mi>Cu</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mi mathvariant="normal">w</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mi mathvariant="normal">H</mml:mi><mml:mo>+</mml:mo></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>Cu</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msup><mml:mi>Cu</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:math></alternatives></disp-formula>Here, <italic toggle="yes">k</italic>
<sub>1</sub>, <italic toggle="yes">k</italic>
<sub>2</sub>, <italic toggle="yes">k</italic>
<sub>3</sub>
<sup>Cu</sup> and <italic toggle="yes">k</italic>
<sub>6</sub>
<sup>Cu</sup> are the rate constants
defined above, <italic toggle="yes">k</italic>
<sub>0</sub> is the rate constant
characterizing the spontaneous dissociation mechanism, <italic toggle="yes">K</italic>
<sub>w</sub> is the ionic product of water (fixed at p<italic toggle="yes">K</italic>
<sub>w</sub> = 13.72) and <italic toggle="yes">K</italic>
<sub>Cu</sub> is the
equilibrium constant for the formation of the ternary complex (<italic toggle="yes">K</italic>
<sub>Cu</sub>= [LaLCu]/[Cu<sup>2+</sup>]&#173;[LaL]). The least-squares
fits of the kinetic data afforded the rate constants shown in <xref rid="tbl4" ref-type="table">Table <xref rid="tbl4" ref-type="table"/>
</xref> as well as the value
of <italic toggle="yes">K</italic>
<sub>Cu</sub>. The values of <italic toggle="yes">k</italic>
<sub>0</sub> obtained during the fitting procedure were negative
or had very large errors, indicating that the spontaneous pathway
does not contribute to complex dissociation under the conditions used
for our kinetic experiments. This is not surprising considering that
the dissociation through formation of a dinuclear hydroxo-complex
plays an important role at the pH values in which spontaneous dissociation
may contribute.</p><table-wrap position="float" id="tbl4" orientation="portrait"><label>4</label><caption><title>Rate and Equilibrium Constants and
Half-live Values Characterizing the Dissociation Reactions of [La&#173;(TPAEN)]<sup>&#8722;</sup> and [La&#173;(TPADAC)]<sup>&#8722;</sup> (25 &#176;C, 0.15
M NaCl)</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="center" colspan="1" rowspan="1">&#160;</th><th align="center" colspan="1" rowspan="1">
<bold>TPAEN</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th><th align="center" colspan="1" rowspan="1">
<bold>TPADAC</bold>
<sup>
<bold>4&#8209;</bold>
</sup>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">k</italic>
<sub>1</sub> (M<sup>&#8211;1</sup>&#160;s<sup>&#8211;1</sup>)</td><td align="left" colspan="1" rowspan="1">2.24&#160;&#177;&#160;0.13</td><td align="left" colspan="1" rowspan="1">0.097&#160;&#177;&#160;0.036</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">k</italic>
<sub>2</sub> (M<sup>&#8211;2</sup>&#160;s<sup>&#8211;1</sup>)</td><td align="left" colspan="1" rowspan="1">110.93&#160;&#177;&#160;10.42</td><td align="left" colspan="1" rowspan="1">232.3&#160;&#177;&#160;36.8</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">k</italic>
<sub>3</sub>
<sup>Cu</sup> (M<sup>&#8211;1</sup>&#160;s<sup>&#8211;1</sup>)</td><td align="left" colspan="1" rowspan="1">0.74&#160;&#177;&#160;0.05</td><td align="left" colspan="1" rowspan="1">(7.8&#160;&#177;&#160;2.2)&#215;10<sup>&#8211;3</sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">k</italic>
<sub>6</sub>
<sup>Cu</sup> (M<sup>&#8211;2</sup>&#160;s<sup>&#8211;1</sup>)</td><td align="left" colspan="1" rowspan="1">(7.2&#160;&#177;&#160;0.5)&#215;10<sup>8</sup>
</td><td align="left" colspan="1" rowspan="1">(1.5&#160;&#177;&#160;0.3)&#215;10<sup>7</sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">K</italic>
<sub>Cu</sub> (M<sup>&#8211;1</sup>)</td><td align="left" colspan="1" rowspan="1">42.0&#160;&#177;&#160;4.5</td><td align="left" colspan="1" rowspan="1">74.3&#160;&#177;&#160;30.2</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">k</italic>
<sub>obs</sub> (s<sup>&#8211;1</sup>) for
[Cu<sup>2+</sup>] = 1 &#956;M<xref rid="t4fn1" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">3.45&#160;&#215;&#160;10<sup>&#8211;4</sup>
</td><td align="left" colspan="1" rowspan="1">7.381&#160;&#215;&#160;10<sup>&#8211;6</sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">k</italic>
<sub>obs</sub> (s<sup>&#8211;1</sup>) for
[Cu<sup>2+</sup>] = 1 nM<xref rid="t4fn1" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">4.34&#160;&#215;&#160;10<sup>&#8211;7</sup>
</td><td align="left" colspan="1" rowspan="1">1.123&#160;&#215;&#160;10<sup>&#8211;8</sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">t</italic>
<sub>1/2</sub> (h) for [Cu<sup>2+</sup>] = 1 &#956;M<xref rid="t4fn1" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">0.56</td><td align="left" colspan="1" rowspan="1">26.1</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">t</italic>
<sub>1/2</sub> (h) for [Cu<sup>2+</sup>] = 1 nM<xref rid="t4fn1" ref-type="table-fn"/>
</td><td align="left" colspan="1" rowspan="1">443.9</td><td align="left" colspan="1" rowspan="1">1.71&#160;&#215;&#160;10<sup>4</sup>
</td></tr></tbody></table><table-wrap-foot><fn id="t4fn1"><label>a</label><p>Calculated at pH=
7.4.</p></fn></table-wrap-foot></table-wrap><p>The rate constants
shown in <xref rid="tbl4" ref-type="table">Table <xref rid="tbl4" ref-type="table"/>
</xref> evidence
that [La&#173;(TPAEN)]<sup>&#8722;</sup> is more
prone to dissociation than [La&#173;(TPADAC)]<sup>&#8722;</sup> following
both the acid- and metal-assisted pathways. This is clearly reflected
in the dissociation rates and half-lives calculated at pH 7.4. The
half-live calculated using a 1 &#956;M concentration of Cu<sup>2+</sup> is &#8764;46 times longer for [La&#173;(TPADAC)]<sup>&#8722;</sup> than
for [La&#173;(TPAEN)]<sup>&#8722;</sup>, while this value is reduced to
&#8764;38 using a [Cu<sup>2+</sup>] of 1 nM. However, it is important
to note that Cu is strongly and inertly bound in blood, and even rather
strong ligands cannot retrieve it from ceruloplasmin, to which copper
is bound at &#8764;15 &#956;M concentrations. A small fraction of
the copper present in blood is bound to serum albumin (&#8764;1 &#956;M)
with an association constant of ca. 10<sup>13</sup>, and thus strong
chelators are required to release it.<named-content content-type="bibref-group">
<xref rid="ref67" ref-type="bibr"/>&#8722;<xref rid="ref68" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref69" ref-type="bibr"/>
</named-content> The low values of <italic toggle="yes">K</italic>
<sub>Cu</sub> determined from the fits of the kinetic data
indicate a weak association of both [La&#173;(TPADAC)]<sup>&#8722;</sup> and [La&#173;(TPAEN)]<sup>&#8722;</sup>, making the release of copper
from blood proteins very unlikely. Thus, it is likely that the spontaneous
and proton-assisted dissociation pathways are the most relevant mechanisms
under physiological conditions.</p></sec><sec id="sec2.5"><title>Radiolabeling Studies with <sup>135</sup>La<sup>3+</sup>
</title><p>H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC both demonstrated highly
efficient incorporation of <sup>135</sup>La<sup>3+</sup>, achieving
radiochemical purities greater than 99% (<italic toggle="yes">n</italic> = 6) under
optimized conditions. These conditions included using a 3 &#956;M
ligand concentration (H<sub>4</sub>TPAEN or H<sub>4</sub>TPADAC),
a short reaction time of one minute, and maintaining the pH between
4 and 5 at room temperature. Under these settings, the reactions produced
high molar activities of 299.4 MBq/nmol for H<sub>4</sub>TPAEN and
326.8 MBq/nmol for H<sub>4</sub>TPADAC. Adjustments such as increasing
the ligand concentration or prolonging the reaction time at the same
pH yielded comparable results (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig"/>
</xref>), indicating that the process is robust. When reactions
were carried out outside the optimal pH range, specifically at pH
3&#8211;4 and 5&#8211;6, the radiochemical purity dropped slightly
to around 90% for both ligands. To reach the ideal pH window, the
initial pH 2 <sup>135</sup>La<sup>3+</sup> solution was adjusted using
a 1 M sodium acetate buffer at pH 9. Overall, these results confirm
that both H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC enable rapid
and effective radiolabeling under mild conditions, with minimal input
material and time. The study highlights that pH, ligand concentration,
and reaction time are key factors in radiolabeling efficiency, but
that optimal labeling can be reliably achieved with simple, quick
protocols. This represents a clear advantage of these acyclic chelators
when compared with H<sub>4</sub>DOTA, which requires heating to 70
&#176;C for 60 min to achieve a radiochemical purity of 97% (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S31</ext-link>, Supporting Information).</p><fig position="float" id="fig7" fig-type="figure" orientation="portrait"><label>7</label><caption><p>Labeling tests
of both H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC
with [<sup>135</sup>La]&#173;La<sup>3+</sup> carried out under different
reaction conditions to set the &#8220;sweet spot&#8221;. Top: pH-dependency
for 3 &#956;M ligand concentration and 1 min of reaction time; Center:
Concentration-dependency at 1 min of reaction time and pH 4&#8211;5;
Bottom: Reaction time for a 3 &#956;M ligand concentration and pH
4&#8211;5. (RCI: Radiochemical Incorporation).</p></caption><graphic id="gr8" position="float" orientation="portrait" xlink:href="jm5c01558_0008.jpg"/></fig></sec><sec id="sec2.6"><title>Stability Experiments</title><p>Both radiolanthanum complexes
remained stable in whole mouse blood and human serum for up to 60
min. [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> was stable across
all tested buffer solutions. In contrast, [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> showed reduced stability at pH 2.2, with radiochemical
purity dropping to 60% after 1 h and to 8% after 48 h (<xref rid="fig8" ref-type="fig">Figure <xref rid="fig8" ref-type="fig"/>
</xref>). Radio-TLC analysis of the
degraded [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> sample
revealed two distinct peaks with different R<sub>
<italic toggle="yes">f</italic>
</sub> values, indicating the formation of new radiolabeled compounds
and degradation of the original complex.</p><fig position="float" id="fig8" fig-type="figure" orientation="portrait"><label>8</label><caption><p>
<italic toggle="yes">In vitro</italic> stability studies of both complexes in
buffer solutions (a and b), and in human serum and mouse blood at
37 &#176;C (c and d).</p></caption><graphic id="gr9" position="float" orientation="portrait" xlink:href="jm5c01558_0009.jpg"/></fig><p>However, no free <sup>135</sup>La was detected. The nature of these
new compounds was not further investigated. These results suggest
that while both complexes are stable in biological fluids, [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> is sensitive to highly acidic
conditions. This can be attributed to the lower thermodynamic stability
of the TPADAC<sup>4&#8211;</sup> complex when compared to [La&#173;(TPAEN)]<sup>&#8722;</sup>, as indicated by the corresponding pLa values and
the speciation diagrams shown in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig"/>
</xref>.</p></sec><sec id="sec2.7"><title>Challenge Experiments</title><p>To evaluate
the stability of
[<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup>, both complexes were challenged
with well-known macrocyclic and acyclic chelators: H<sub>4</sub>DOTA,
H<sub>3</sub>NOTA, H<sub>4</sub>TETA, H<sub>4</sub>EDTA, DiAmSar,
and H<sub>2</sub>MACROPA (<xref rid="cht1" ref-type="fig">Chart <xref rid="cht1" ref-type="fig"/>
</xref>). H<sub>4</sub>DOTA and H<sub>2</sub>MACROPA have
previously demonstrated efficient radiolabeling with radiolanthanum
isotopes and served as benchmarks, while the other ligands were included
to test thermodynamic stability. Radiolabeling results confirmed that
both DOTA and MACROPA form stable complexes with <sup>135</sup>La.
[<sup>135</sup>La]&#173;[La&#173;(DOTA)] (R<sub>
<italic toggle="yes">f</italic>
</sub> = 0.41)
reached 90% radiochemical purity (<italic toggle="yes">n</italic> = 3) after 1
h at 37 &#176;C, and 97% (<italic toggle="yes">n</italic> = 3) at 70 &#176;C under
the same time. [<sup>135</sup>La]&#173;[La&#173;(MACROPA)] (R<sub>
<italic toggle="yes">f</italic>
</sub> = 0.347) achieved 99% purity (<italic toggle="yes">n</italic> = 3) after
5 min at 37 &#176;C. In contrast, H<sub>3</sub>NOTA, H<sub>4</sub>EDTA, H<sub>4</sub>TETA, and DiAmSar did not form stable complexes
with <sup>135</sup>La under the tested conditions (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Figure S31</ext-link>, Supporting Information). The radio-TLC system
clearly distinguished the radiolabeled species, with [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> showing R<sub>
<italic toggle="yes">f</italic>
</sub> values of 0.33
and 0.39, respectively&#58872;distinct from those of the DOTA and
MACROPA analogues. In challenge experiments, both [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> maintained high radiochemical purity (up to 98%) after 120 min in
the presence of excess competing ligands. No transchelation was observed,
confirming the high kinetic and thermodynamic stability of these complexes
in competitive environments (<xref rid="fig9" ref-type="fig">Figure <xref rid="fig9" ref-type="fig"/>
</xref>).</p><fig position="float" id="fig9" fig-type="figure" orientation="portrait"><label>9</label><caption><p>Challenge experiments with [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> (top) and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> (bottom)
using H<sub>4</sub>DOTA, H<sub>3</sub>NOTA, H<sub>4</sub>EDTA, H<sub>4</sub>TETA, DiAmSar and MACROPA.</p></caption><graphic id="gr10" position="float" orientation="portrait" xlink:href="jm5c01558_0010.jpg"/></fig></sec><sec id="sec2.8"><title>
<italic toggle="yes">In Vivo</italic> Studies</title><p>
<italic toggle="yes">In vivo</italic> stability of complexes [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> was studied
in healthy mice. Blood compartment analysis (blood cells, plasma proteins,
and supernatant) showed that both [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> were largely bioavailable in the supernatant, ranging from 60 to
80% similarly to [<sup>135</sup>La]&#173;[La&#173;(MACROPA)]<sup>+</sup> (<xref rid="fig10" ref-type="fig">Figure <xref rid="fig10" ref-type="fig"/>
</xref>). However, stability
differed significantly between the two complexes.</p><fig position="float" id="fig10" fig-type="figure" orientation="portrait"><label>10</label><caption><p>
<italic toggle="yes">In vivo</italic> metabolic profiling of [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> (top), [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> (center)
and [<sup>135</sup>La]&#173;[La&#173;(MACROPA)]<sup>+</sup>, and blood compartments
(blood cells, plasma proteins, and supernatant).</p></caption><graphic id="gr11" position="float" orientation="portrait" xlink:href="jm5c01558_0011.jpg"/></fig><p>Radio-TLC analysis of the supernatant revealed that [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> remained intact and stable even
after 60 min <italic toggle="yes">in vivo</italic>, equally to [<sup>135</sup>La]&#173;[La&#173;(MACROPA)]<sup>+</sup>. In contrast, [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> showed rapid degradation, with around 80% of the complex breaking
down within the first 5 min and approximately 95% degraded by 60 min
postadministration (<xref rid="fig11" ref-type="fig">Figure <xref rid="fig11" ref-type="fig"/>
</xref>). These results indicate that while both complexes circulate
in the plasma, [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> demonstrates
significantly greater <italic toggle="yes">in vivo</italic> stability than [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup>.</p><fig position="float" id="fig11" fig-type="figure" orientation="portrait"><label>11</label><caption><p>Radio-TLC analysis of
the supernatant after <italic toggle="yes">in vivo</italic> administration of [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup>, [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(MACROPA)]<sup>+</sup>.</p></caption><graphic id="gr12" position="float" orientation="portrait" xlink:href="jm5c01558_0012.jpg"/></fig><p>The higher <italic toggle="yes">in vivo</italic> stability of
[<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> compared with [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> is somewhat surprising
considering previous studies,
in which chelator rigidification using cyclohexyl spacers was found
to improve complex stability of [<sup>177</sup>Lu]&#173;Lu<sup>3+</sup>,
[<sup>90</sup>Y]&#173;Y<sup>3+</sup> and [<sup>67</sup>Ga]&#173;Ga<sup>3+</sup> complexes.<named-content content-type="bibref-group">
<xref rid="ref34" ref-type="bibr"/>,<xref rid="ref70" ref-type="bibr"/>
</named-content> Furthermore, the dissociation
kinetics studies presented above indicate a slower dissociation of
[<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> compared with [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> following the proton-
and copper-assisted dissociation pathways. These results highlight
the difficulties in predicting the stability of radio-complexes <italic toggle="yes">in vivo</italic> using kinetic data generated <italic toggle="yes">in vitro</italic>. The complexity of the environment in which the complex is dissolved <italic toggle="yes">in vivo</italic> makes predictions particularly difficult, as competition
of cations, anions and proteins may facilitate complex dissociation.<named-content content-type="bibref-group">
<xref rid="ref71" ref-type="bibr"/>&#8722;<xref rid="ref72" ref-type="bibr" specific-use="suppress-in-print"/>
<xref rid="ref73" ref-type="bibr"/>
</named-content> The higher thermodynamic stability of the complex with TPAEN<sup>4&#8211;</sup> compared with the cyclohexyl analogue (see above)
may be a factor contributing to an increased <italic toggle="yes">in vivo</italic> stability.<xref rid="ref74" ref-type="bibr"/> The Log&#8239;P values
were determined to be &#8722;1.78 &#177; 0.09 and &#8722;1.26 &#177;
0.06 for [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup>, respectively. Thus,
even when the latter is slightly more lipophilic, the negative value
of the logarithm of the partition coefficient indicates that both
complexes have a higher affinity for the aqueous phase compared to
the organic (lipid) phase. As a result, no major differences in clearance
kinetics are expected for the two complexes.<xref rid="ref75" ref-type="bibr"/>
</p></sec></sec><sec id="sec3"><title>Conclusions</title><p>The H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC ligands form ten-coordinate
complexes both in the solid state and in solution endowed with high
thermodynamic stability. The structural and thermodynamic data indicate
that H<sub>4</sub>TPAEN provides a more efficient binding of the large
La<sup>3+</sup> ion than the cyclohexyl analogue H<sub>4</sub>TPADAC,
in contrast to the trends observed for complexes with smaller metal
ions.</p><p>The acyclic ligands H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC
were efficiently radiolabeled with <sup>135</sup>La, achieving high
radiochemical yields within short reaction times. Stability studies,
both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>, showed
that [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> displayed significantly
higher stability compared to [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup>. Among the two, H<sub>4</sub>TPAEN stood out as the most promising
ligand, forming a stable complex with radiolanthanum under mild conditions
and maintaining its integrity in biological environments. Our results
indicate that the stability of [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup>
<italic toggle="yes">in vivo</italic> is comparable to that of the [<sup>135</sup>La]&#173;[La&#173;(MACROPA)]<sup>+</sup>, as no signs of significant dissociation
were observed for any of the complexes. Both TPAEN<sup>4&#8211;</sup> and the leading chelator for large metal ions MACROPA<sup>2&#8211;</sup>, can be radiolabeled with [<sup>135</sup>La]&#173;La<sup>3+</sup> under
very mild conditions, in contrast to the ubiquitous DOTA<sup>4&#8211;</sup>,<xref rid="ref21" ref-type="bibr"/> which displays slow radiolabeling
kinetics at 37 &#176;C. Radiolabeling under mild conditions is critical
for the use of radio-conjugates containing temperature sensitive targeting
units like antibodies. Thus, the results reported here support H<sub>4</sub>TPAEN as a strong candidate for further development. Given
its performance, H<sub>4</sub>TPAEN should be explored as a bifunctional
chelating agent for conjugation to biomolecules such as peptides and
proteins, potentially expanding its use in targeted radiopharmaceutical
applications. Studies involving other large f-block radiometals (i.e., <sup>225</sup>Ac) are currently underway.</p></sec><sec id="sec4"><title>Experimental
Section</title><sec id="sec4.1"><title>General Information</title><p>Solvents and reagents were purchased
from commercial sources and were directly used without further purification.
Medium performance liquid chromatography (MPLC) was performed in a
Puriflash XS 420 InterChim Chromatographer equipped with a UV-DAD
detector in reverse phase, using a 20 g BGB Aquarius C18AQ reversed-phase
column (100 &#197;, spherical, 15 &#956;m) with a 0.1% TFA aqueous
solution (phase A) and CH<sub>3</sub>CN with 20% of phase A (phase
B) as the mobile phases (flow rate 15 mL/min). Preparative high performance
liquid chromatography (HPLC) was performed using an Agilent 1260 Infinity
II instrument equipped with an UV variable wavelength detector, in
manual injection and collection mode, using an Agilent InfinityLab
ZORBAX 5 Eclipse Plus C18 (5 &#956;m, 21.2 &#215; 250 mm) and 10
mM ammonium acetate aqueous solution (phase A) and CH<sub>3</sub>CN
with 10% of phase A (phase B) as the mobile phases, operating at a
flow rate of 20 mL/min. Analytical HPLC analysis of the pure ligands
were performed in a Thermo Scientific UltiMate 3000 connected to a
photodiode array detector using a Polar-C18 Luna Omega analytical
column from Phenomenex (100 &#197;, 3 &#956;m, 150 &#215; 2.1 mm),
with H<sub>2</sub>O and CH<sub>3</sub>CN + 0.04% TFA as the mobile
phases (flow rate of 0.3 mL/min). All compounds are &gt;97% pure by
HPLC
analysis. High-resolution electrospray-ionization time-of-flight ESI-TOF
mass spectra were recorded in positive mode using a LTQ-Orbitrap Discovery
Mass Spectrometer coupled to a Thermo Accela HPLC. Aqueous solutions
were lyophilized using a Biobase BK-FD10 Series apparatus. <sup>1</sup>H and <sup>13</sup>C NMR spectra of the ligands and their precursors
were recorded on a Bruker AVANCE 500 or 400 MHz. Elemental analyses
of the ligands were performed using a ThermoQuest Flash EA 1112 elemental
analyzer.</p><sec id="sec4.1.1"><title>Synthesis of <italic toggle="yes">N,N,N&#8242;N&#8242;</italic>-tetrakis&#173;[(6-carboxypyridin-2-yl)&#173;methyl]-ethylenediamine
(H<sub>4</sub>TPAEN)</title><p>To a solution of 6-chloromethylpyridine-2-carboxylic
acid ethyl ester (892.8 mg, 4.46 mmol) in acetonitrile (10 mL), K<sub>2</sub>CO<sub>3</sub> (609.6 mg, 4.40 mmol) and ethylenediamine (67
&#956;L, 1 mmol) were consecutively added under argon atmosphere.
The reaction mixture was refluxed for 48 h, followed by the filtration
and evaporation of the solvent to give an orange oil. The crude product
was then refluxed for 4h in a 6 M HCl aqueous solution (30 mL). After
evaporation of the solvent, the resulting oil was dissolved in MeOH
(2 mL), to which acetone (80 mL) was added to precipitate the product
as an off-white solid. Upon filtration, washing with acetone and then
drying under vacuum, the pure hydrochloric salt of the ligand was
obtained with a global yield of 57% (386.4 mg). <sup>1</sup>H NMR
(500 MHz, D<sub>2</sub>O, pD 2.8, 298 K) &#948; (ppm): 8.05&#8211;7.95
(m, 8H), 7.64 (d, <italic toggle="yes">J</italic> = 7.2 Hz, 4H), 4.54 (s, 8H),
3.82 (s, 4H). <sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O, pD 2.8,
298 K) &#948; (ppm): 166.18, 151.38, 146.43, 141.21, 128.17, 125.37,
58.18, 50.90. Elemental analysis calcd (%) for C<sub>30</sub>H<sub>28</sub>N<sub>6</sub>O<sub>8</sub>&#183;HCl&#183;1.65H<sub>2</sub>O: C 54.04, H 4.88, N 12.60; found C 54.06, H 4.77, N 12.28. Experimental
MS (ESI<sup>+</sup>, H<sub>2</sub>O): <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 601.2046, 623.1864; calculated for [C<sub>30</sub>H<sub>29</sub>N<sub>6</sub>O<sub>8</sub>]<sup>+</sup> 601.2042, calculated for
[C<sub>30</sub>H<sub>28</sub>N<sub>6</sub>NaO<sub>8</sub>]<sup>+</sup> 623.1861.</p></sec><sec id="sec4.1.2"><title>Synthesis of (1<italic toggle="yes">R</italic>,2<italic toggle="yes">R</italic>)-<italic toggle="yes">N,N,N&#8242;,N&#8242;</italic>-tetrakis&#173;[6-carboxypyridin-2-yl)&#173;methyl]&#173;diaminocyclohexane
(H<sub>4</sub>TPADAC)</title><p>To a solution of 6-chloromethylpyridine-2-carboxylic
acid ethyl ester (898.4 mg, 4.5 mmol) in acetonitrile (10 mL), K<sub>2</sub>CO<sub>3</sub> (615 mg, 4.45 mmol) and enantiomerically pure
(1<italic toggle="yes">R</italic>,2<italic toggle="yes">R</italic>)-cyclohexane-1,2-diamine
(114.2 mg, 1 mmol) were consecutively added under argon atmosphere.
The reaction mixture was refluxed for 72 h, followed by the filtration
and evaporation of the solvent to give an orange oil. The crude product
was refluxed for 4 h in a 6 M HCl aqueous solution (30 mL), after
which the solvent was evaporated to give a brown oil. This oil was
dissolved in water (2 mL) and was purified by reverse phase MPLC (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Table S5</ext-link>, Supporting Information). The desired
compound eluted at 12% CH<sub>3</sub>CN (15% phase B, retention time
25.6 min). The fraction of interest was lyophilized to obtain an off-white
solid (211.6 mg, 32% yield). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O, pD 2.2, 298 K) &#948; (ppm): 8.35&#8211;7.14 (m, 12H), 4.39
(m, 6H), 4.14 (d, <italic toggle="yes">J</italic> = 8.8 Hz, 2H), 3.96 (s, 2H),
2.51 (d, <italic toggle="yes">J</italic> = 11.7 Hz, 2H), 2.03 (d, <italic toggle="yes">J</italic> = 9.4 Hz, 2H), 1.77 (q, <italic toggle="yes">J</italic> = 11.8, 8.9 Hz, 2H),
1.53 (p, <italic toggle="yes">J</italic> = 11.8, 10.0 Hz, 2H).<sup>13</sup>C NMR
(126 MHz, D<sub>2</sub>O, pD 2.2, 298 K) &#948; (ppm): 166.04, 153.80,
152.29, 146.52, 142.66, 140.09, 129.21, 126.79, 125.29, 62.28, 56.14,
52.38, 23.88, 23.55. Elemental analysis calcd (%) for C<sub>34</sub>H<sub>34</sub>N<sub>6</sub>O<sub>8</sub>&#183;2C<sub>2</sub>F<sub>3</sub>O<sub>2</sub>H&#183;1.5H<sub>2</sub>O: C 52.00, H 4.48, N
9.57; found C 51.95, H 4.43, N 9.62. Experimental MS (ESI<sup>+</sup>, H<sub>2</sub>O): <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 655.2576;
calculated for [C<sub>34</sub>H<sub>35</sub>N<sub>6</sub>O<sub>8</sub>]<sup>+</sup> 655.2511.</p><p>Both chelators were further purified
by preparative HPLC before performing the radiolabeling experiments
to ensure high purity (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Table S6, Figures S34&#8211;S35</ext-link>, Supporting Information).</p></sec></sec><sec id="sec4.2"><title>General Procedure for the
Synthesis of the Lanthanum Complexes</title><p>The La<sup>3+</sup> complexes
were prepared <italic toggle="yes">in situ</italic> by adding 1.1 equiv of LaCl<sub>3</sub>&#183;6H<sub>2</sub>O to
a solution of the corresponding chelator in deuterated water (0.4
mL, pD 6.6) and stirring for 5 min. Since the complexation process
lowers the pD of the mixture, a diluted solution of NaOD was used
to adjust de pD above pD 7. The formation of the complexes was monitored
using NMR.</p><sec id="sec4.2.1"><title>Synthesis of [La&#173;(TPAEN)]<sup>&#8722;</sup>
</title><p>Following
the general procedure the desired compound was obtained. <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O, pD 7.4, 298 K) &#948; (ppm): 7.98
(t, <italic toggle="yes">J</italic> = 7.8 Hz, 2H), 7.95&#8211;7.86 (m, 4H), 7.76
(d, <italic toggle="yes">J</italic> = 7.6 Hz, 2H), 7.47 (d, <italic toggle="yes">J</italic> =
7.8 Hz, 2H), 7.41 (d, <italic toggle="yes">J</italic> = 7.7 Hz, 2H), 4.02 (d, <italic toggle="yes">J</italic> = 17.1 Hz, 2H), 3.91 (d, <italic toggle="yes">J</italic> = 15.5 Hz,
2H), 3.81 (d, <italic toggle="yes">J</italic> = 17.3 Hz, 2H), 3.25 (d, <italic toggle="yes">J</italic> = 15.7 Hz, 2H), 2.84 (d, <italic toggle="yes">J</italic> = 10.4 Hz,
2H), 2.67 (d, <italic toggle="yes">J</italic> = 10.3 Hz, 2H). <sup>13</sup>C NMR
(126 MHz, D<sub>2</sub>O, pD 7.4, 298 K) &#948; (ppm): 173.49, 171.51,
160.35, 155.31, 151.74, 150.94, 141.15, 140.39, 126.10, 124.65, 123.70,
123.57, 63.37, 62.43, 59.36. Experimental MS (ESI<sup>+</sup>, H<sub>2</sub>O): <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 737.0875, 369.0476,
759.0606; calculated for [C<sub>30</sub>H<sub>26</sub>LaN<sub>6</sub>O<sub>8</sub>]<sup>+</sup> 737.0871, calculated for [C<sub>30</sub>H<sub>27</sub>LaN<sub>6</sub>O<sub>8</sub>]<sup>2+</sup> 369.0472,
calculated for [C<sub>30</sub>H<sub>25</sub>LaN<sub>6</sub>NaO<sub>8</sub>]<sup>+</sup> 759.0690.</p></sec><sec id="sec4.2.2"><title>Synthesis of [La&#173;(TPADAC)]<sup>&#8722;</sup>
</title><p>Following
the general procedure the desired compound was obtained. <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O, pD 7.8, 298 K) &#948; (ppm): 8.13&#8211;7.87
(m, 6H), 7.77 (s, 2H), 7.46 (d, <italic toggle="yes">J</italic> = 17.5 Hz, 4H),
4.15 (d, <italic toggle="yes">J</italic> = 15.0 Hz, 2H), 4.07 (d, <italic toggle="yes">J</italic> = 13.9 Hz, 2H), 3.59 (d, <italic toggle="yes">J</italic> = 13.9 Hz, 2H), 3.13
(d, <italic toggle="yes">J</italic> = 15.1 Hz, 2H), 2.44 (s, 2H), 2.17&#8211;2.03
(m, 2H), 1.83 (s, 2H), 1.64 (s, 2H), 1.21&#8211;1.00 (m, 2H).<sup>13</sup>C NMR (126 MHz, D<sub>2</sub>O, pD 7.8, 298 K) &#948; (ppm):
173.28, 171.21, 159.39, 155.22, 151.82, 150.68, 141.69, 140.58, 126.51,
124.99, 123.75, 123.39, 66.05, 59.91, 53.68, 24.30, 24.00. Experimental
MS (ESI<sup>&#8211;</sup>, H<sub>2</sub>O): <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 789.1205; calculated for [C<sub>34</sub>H<sub>30</sub>LaN<sub>6</sub>O<sub>8</sub>]<sup>&#8722;</sup> 789.1194.</p></sec></sec><sec id="sec4.3"><title>Equilibrium and Kinetic Measurements</title><p>The chemicals
used in the studies were of the highest analytical grade. The LaCl<sub>3</sub> solution was prepared by dissolving La<sub>2</sub>O<sub>3</sub> (Merck, 99.99%) in 6.0 M HCl and evaporating the excess of acid.
The concentrations of the metal chloride solutions were determined
by complexometric titration with the use of a standardized Na<sub>2</sub>H<sub>2</sub>EDTA solution and xylenol orange (LnCl<sub>3</sub>) and murexid (CuCl<sub>2</sub>) indicators.</p><p>The pH-potentiometric
titrations were carried out with a Methrohm 785 DMP titrator using
a Metrohm-6.0233.100 combined electrode. The titrated solutions (5.000
mL) were thermostated at 25 &#176;C and stirred and kept under inert
gas atmosphere (N<sub>2</sub>) to avoid the effect of CO<sub>2</sub>. The pH-calibration of the electrode was performed using KH-phthalate
(pH = 4.005) and borax (pH = 9.177) buffers. The concentrations of
the ligand stock solutions were determined by pH-potentiometric titration.
The protonation constants of the TPAEN<sup>4&#8211;</sup> (in the
pH range of 2.19&#8211;12.00 a total of 213 data pairs by titrating
a 2.72 mM a ligand solution) and TPADAC<sup>4&#8211;</sup> (in the
pH range of 1.88&#8211;11.85 a total of 208 data pairs by titrating
a 2.32 mM ligand solution), the stability and protonation constants
of the complexes formed with La<sup>3+</sup> and the formation constants
of their dinuclear complexes were determined by pH-potentiometric
titration. The metal-to-ligand concentration ratios were 1:1 and 2:1.
For the 1:1 ratio a total of 240 data pairs were recorded for a H<sub>4</sub>TPAEN concentration of 2.29 mM in the pH range of 1.77&#8211;11.86,
while a total of 222 data pairs were collected in the pH range 1.72&#8211;11.85
for a 2.72 mM solution of H<sub>4</sub>TPADAC. For the 2:1 ratio we
collected 259 data pairs for a 2.31 mM solution of H<sub>4</sub>TPAEN
in the pH range of 1.73&#8211;11.82, and 259 data pairs for a 2.71
mM concentration of H<sub>4</sub>TPADAC in the pH range of 1.70&#8211;11.85.
The calculation of [H<sup>+</sup>] from the measured pH values was
performed with the use of the method proposed by Irving et al.<xref rid="ref76" ref-type="bibr"/> by titrating a 0.01 M HCl solution (<italic toggle="yes">I</italic> = 0.15 M NaCl) with a standardized NaOH solution. The
differences between the measured and calculated pH values were used
to obtain the [H<sup>+</sup>] concentrations from the pH-data obtained
in the titrations. The ionic product of water was determined from
the same experiment in the pH range 11.25&#8211;11.85. The protonation
and stability constants were calculated from the titration data with
the PSEQUAD program.<xref rid="ref77" ref-type="bibr"/> The quality of the
fits was assessed with the fitting parameter (FP) calculated by PSEQUAD,
which is defined as<disp-formula id="eq2"><label>2</label><alternatives><graphic position="float" orientation="portrait" xlink:href="jm5c01558_m002.jpg"/><mml:math id="d1e3718" display="block"><mml:mi>FP</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:mfrac><mml:mrow><mml:mrow><mml:munderover><mml:mo>&#8721;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:munderover></mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>calc</mml:mi></mml:mrow></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>meas</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>k</mml:mi></mml:mrow></mml:mfrac></mml:msqrt></mml:math></alternatives></disp-formula>
</p><p>In <xref rid="eq2" ref-type="disp-formula">eq <xref rid="eq2" ref-type="disp-formula"/>
</xref>, <italic toggle="yes">V</italic>
<sub>
<italic toggle="yes">i</italic>,calc</sub> and <italic toggle="yes">V</italic>
<sub>
<italic toggle="yes">i</italic>,meas</sub> are the calculated and experimental volumes
of base added at a given pH, <italic toggle="yes">n</italic> is the number of data
pairs and k is the number of fitted parameters.</p><p>The rates of
the metal exchange reactions of the [La&#173;(TPAEN)]<sup>&#8722;</sup> and [La&#173;(TPADAC)]<sup>&#8722;</sup> complexes with
Cu&#173;(II) were studied by using UV&#8211;vis spectrophotometry following
the formation of corresponding Cu&#173;(II) complexes. The metal exchange
reactions of [La&#173;(TPAEN)]<sup>&#8722;</sup> and [La&#173;(TPADAC)]<sup>&#8722;</sup> were examined by conventional spectrophotometric methods tracking
the changes in absorption at 305 nm within the pH range of 1.84 to
4.94 (for [La&#173;(TPAEN)]<sup>&#8722;</sup>). The concentration of the
complexes was 0.252 mM, while the Cu&#173;(II) ion was applied in high excess
(12 to 42 times) to ensure pseudo-first-order conditions. The temperature
was maintained at 25 &#176;C, and the ionic strength of the solutions
was kept constant at 0.15 M NaCl. Dimethylpiperazine (DMP, 50 mM)
buffer was used to maintain the pH constant (log <italic toggle="yes">K</italic>
<sub>2</sub>
<sup>H</sup> = 4.18) in the pH range of 3.40 to 4.89
(for [La&#173;(TPADAC)]<sup>&#8722;</sup>). At lower pH, the data were
supplemented by following the reactions in the range pH of 2.57 to
3.23 using chloroacetic acid (log <italic toggle="yes">K</italic>
<sub>2</sub>
<sup>H</sup> = 2.87) at the same concentration. The pseudo-first-order
rate constants (<italic toggle="yes">k</italic>
<sub>obs</sub>) were calculated
by fitting the absorbance vs time data to <xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula"/>
</xref>:<disp-formula id="eq3"><label>3</label><alternatives><graphic position="float" orientation="portrait" xlink:href="jm5c01558_m003.jpg"/><mml:math id="d1e3817" display="block"><mml:msub><mml:mi>A</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>e</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>&#8722;</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mi>obs</mml:mi></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mi>e</mml:mi></mml:msub></mml:math></alternatives></disp-formula>where <italic toggle="yes">A</italic>
<sub>
<italic toggle="yes">t</italic>
</sub>, <italic toggle="yes">A</italic>
<sub>
<italic toggle="yes">0</italic>
</sub> and <italic toggle="yes">A</italic>
<sub>
<italic toggle="yes">e</italic>
</sub> are the absorbances recorded
at time <italic toggle="yes">t</italic>, at the start of the reaction and upon
reaching equilibrium, respectively. The fittings were performed with
the computer program Micromath Scientist, version 2.0 (Salt Lake City,
UT) by using a standard least-squares procedure.</p></sec><sec id="sec4.4"><title>Crystal Structure
Determinations</title><p>Single crystals of
[La&#173;(HTPAEN)] were obtained by adding LaCl<sub>3</sub>&#183;6H<sub>2</sub>O (12.9 mg, 0.037 mmol) to a saturated solution of H<sub>4</sub>TPAEN (20 mg, 0.033 mmol) with triethylamine (9.28 &#956;L, 0.066
mmol) in methanol (0.4 mL). Slow evaporation of the solvent afforded
colorless prisms that were analyzed by X-ray diffraction. Single crystals
of [La&#173;(TPADAC)]<sup>&#8722;</sup> were grown by slow evaporation
of a concentrated aqueous solution of the complex, yielding colorless
prisms that were analyzed by X-ray diffraction.</p><p>Crystallographic
data and the structure refinement parameters corresponding to [H<sub>5</sub>TPAEN]&#173;Cl&#183;3H<sub>2</sub>O, [La&#173;(HTPAEN)]&#183;12H<sub>2</sub>O and [LaCl&#173;(H<sub>2</sub>O)<sub>3</sub>]&#173;[La&#173;(TPADAC)]&#173;Cl&#183;3H<sub>2</sub>O are given in <ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">Table S7</ext-link>, Supporting
Information. Measurements were performed on a Bruker D8 Venture diffractometer
with a Photon 100 CMOS detector at 100 K and Mo&#8211;K&#945; radiation
(&#955; = 0.71073 &#197;) generated by an Incoatec high brillance
microfocus source equipped with Incoatec Helios multilayer optics.
The software or APEX4<xref rid="ref78" ref-type="bibr"/> was used for collecting
frames of data, indexing reflections, and the determination of lattice
parameters, SAINT<xref rid="ref79" ref-type="bibr"/> for integration of
intensity of reflections, and SADABS<xref rid="ref80" ref-type="bibr"/> for
scaling and empirical absorption correction. The SHELXT<xref rid="ref81" ref-type="bibr"/> program was used for solving the structure by
dual-space methods. All non-hydrogen atoms were refined with anisotropic
thermal parameters by full-matrix least-squares calculations on F<sup>2</sup> using the program SHELXL-2014.<xref rid="ref82" ref-type="bibr"/> Hydrogen atoms of the compound were inserted at calculated positions
and constrained with isotropic thermal parameters. For 32109002, highly
disordered solvent molecules were removed using the Solvent Mask routine
from OLEX2.<xref rid="ref83" ref-type="bibr"/> CCDC 2450303, 2450304, and
2449869 contain the supplementary crystallographic data, which can
be obtained free of charge from the Cambridge Crystallographic Data
Centre via <uri xlink:href="http://www.ccdc.ac.uk/data_request/cif">www.ccdc.ac.uk/data_request/cif</uri>.</p></sec><sec id="sec4.5"><title>Radiolabeling Studies with <sup>135</sup>La</title><p>H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC were dissolved in ultrapure deionized
water and then diluted to 10<sup>&#8211;2</sup> M stock solutions;
subsequent dilutions from 10<sup>&#8211;3</sup> to 10<sup>&#8211;6</sup> M of both ligands were prepared. <sup>133/135</sup>La was produced
following the procedure previously reported using <sup>nat</sup>BaCO<sub>3</sub> target,<xref rid="ref2" ref-type="bibr"/> allowing the decay of
coproduced <sup>133</sup>La to leave highly pure <sup>135</sup>La
available. To assess the optimal conditions for radiolabeling both
H<sub>4</sub>TPAEN and H<sub>4</sub>TPADAC, <sup>135</sup>LaCl<sub>3</sub> aliquots (30&#8211;40 MBq, &#8764;pH 1.5) were adjusted
from pH 1.5 to 10 using HCl, NaOH or pH 9 1 M NaOAc buffer; different
H<sub>4</sub>TPAEN/H<sub>4</sub>TPADAC masses (0.01&#8211;10 &#956;g)
and reaction times (1&#8211;60 min) were tested at room temperature.
Percentage of radiochemical conversion was evaluated by reverse phase
radio-TLC using Methanol/10% Ammonium acetate (3/1) as mobile phase
and TLC Aluminum sheets Nano silica gel 60 RP-18W as stationary phase.
All radiolabeling experiments were conducted in triplicate.</p></sec><sec id="sec4.6"><title>Stability
Experiments</title><p>
<italic toggle="yes">In vitro</italic> stability
studies were performed with both [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> at 37 &#176;C with incubation times 0, 1, 4, 24, and 48 h: (a) in
whole mouse blood; (b) buffers 0.1 M glycine-HCl pH 2.2, reaction
media (pH 4&#8211;5), 1 &#215; PBS pH 6.8, Krebs buffer pH 7.4, 1
M NaOAc pH 9.4 and (c) in human serum, and analyzed by radio-TLC.</p></sec><sec id="sec4.7"><title>Challenge Experiments</title><p>H<sub>4</sub>DOTA, H<sub>3</sub>NOTA,
H<sub>4</sub>EDTA, H<sub>4</sub>TETA, DiAmSar and H<sub>2</sub>MACROPA
(10&#215; molar excess of each compared to initial &#8220;cold&#8221;
0.1 &#956;g of H<sub>4</sub>TPAEN/H<sub>4</sub>TPADAC) were incubated
with [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> at 37 &#176;C, and the percentage
of [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and <sup>135</sup>La&#8211;H<sub>4</sub>T remaining intact was assessed by radio-TLC
at 5, 15, 30, 60, and 120 min of incubation. To assess the R<sub>
<italic toggle="yes">f</italic>
</sub> differences between [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup>/ [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> and radio-complexes [<sup>135</sup>La]&#173;[La&#173;(DOTA)]<sup>&#8722;</sup>, [<sup>135</sup>La]&#173;[La&#173;(NOTA)], [<sup>135</sup>La]&#173;[La&#173;(EDTA)]<sup>&#8722;</sup>, [<sup>135</sup>La]&#173;[La&#173;(TETA)]<sup>&#8722;</sup>,
[<sup>135</sup>La]&#173;[La&#173;(DiAmSar)]<sup>3+</sup> and [<sup>135</sup>La]&#173;[La&#173;(MACROPA)]<sup>+</sup>, a labeling experiment was carried out to radiolabel H<sub>4</sub>DOTA, H<sub>3</sub>NOTA, H<sub>4</sub>EDTA, H<sub>4</sub>TETA,
DiAmSar and H<sub>2</sub>MACROPA with <sup>135</sup>La. In short,
H<sub>4</sub>DOTA, H<sub>3</sub>NOTA, H<sub>4</sub>EDTA, H<sub>4</sub>TETA, DiAmSar and H<sub>2</sub>MACROPA (10 &#956;g) were added to
a 4.5 pH-previously buffered <sup>135</sup>La solution (50 &#956;L,
&#8764; 40 MBq) and incubated at 37 and/or 70 &#176;C. Percentage
of radiochemical conversion was evaluated by radio-TLC as stated before
at 5, 15, 30, and 60 min of reaction. All experiments were carried
out in triplicate.</p></sec><sec id="sec4.8"><title>Partition Coefficients</title><p>[<sup>133/135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>133/135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> (90&#8211;100 MBq) were dissolved in 500 &#956;L
of distilled
H<sub>2</sub>O in 1.5 mL Eppendorf tubes, and 500 &#956;L of octan-1-ol
(Sigma-Aldrich (St. Louis, MO)) was added. The tubes were capped and
shaken vigorously for 2&#8211;3 min and subsequently centrifuged
for 30 min (5000 rpm; Rotina 35R, Hettich Zentrifugen, Tuttlingen,
Germany). Aliquots (300 &#956;L) of the resulting organic top layer
(representing [<sup>133/135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> or [<sup>133/135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> dissolved
in octanol), and bottom layer ([<sup>133/135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> or [<sup>133/135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> dissolved in H<sub>2</sub>O) were taken and the radioactivity in
the samples was measured using a GEM35P4&#8211;70-SMP high-purity
germanium detector (ORTEC, Oak Ridge, TN) with ORTEC GammaVision software.
Five octanol &#8211; H<sub>2</sub>O mixtures were analyzed (n = 5),
and the octanol &#8211; water partition coefficient (<italic toggle="yes">P</italic>) was calculated by dividing the octanol-containing radioactivity
by the water-containing radioactivity:<disp-formula id="eq4"><label>4</label><alternatives><graphic position="float" orientation="portrait" xlink:href="jm5c01558_m004.jpg"/><mml:math id="d1e4116" display="block"><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:msub><mml:mi>A</mml:mi><mml:mi>org</mml:mi></mml:msub><mml:msub><mml:mi>A</mml:mi><mml:mi>aq</mml:mi></mml:msub></mml:mfrac></mml:math></alternatives></disp-formula>Here <italic toggle="yes">A</italic>
<sub>org</sub> is the
activity (Bq) in the organic phase (n-octanol) and <italic toggle="yes">A</italic>
<sub>aq</sub> is the activity in the aqueous phase.</p></sec><sec id="sec4.9"><title>
<italic toggle="yes">In
Vivo</italic> Studies</title><p>All animal experiments
followed the guidelines of the Canadian Council on Animal Care (CCAC)
and were approved by the local animal care committee of the Cross
Cancer Institute (animal protocol # AC22264). Control nu/nu Nude mice
were used for analyzing <italic toggle="yes">in vivo</italic> metabolic stability
of both [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> and [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup>. The animals were anesthetized
through inhalation of isoflurane in 100% oxygen (gas flow, 1 L/min).
100&#8211;120 MBq of [<sup>135</sup>La]&#173;[La&#173;(TPAEN)]<sup>&#8722;</sup> or [<sup>135</sup>La]&#173;[La&#173;(TPADAC)]<sup>&#8722;</sup> in &#8764;180
&#956;L saline was injected into the tail vein through a needle catheter.
At 5-, 15-, 30- and 60 min postinjection blood samples of &#8764;20
&#956;L were collected. Blood cells were separated by immediate centrifugation
(5 min at 13,000 rpm). Subsequently, proteins were precipitated by
adding 200 &#956;L of methanol to the supernatant following a second
centrifugation step (5 min at 13,000 rpm). The radioactivity present
in each blood fraction was measured using a HIDEX automated &#947;
counter (Hidex Oy, Turku, Finland). For the evaluation of the <italic toggle="yes">in vivo</italic> metabolic stability of both radiolanthanum-labeled
complexes, the supernatant plasma fractions collected at 5, 15, 30,
and 60 min were analyzed by reverse phase radio-TLC as stated before.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="sifile1" position="float" content-type="local-data" orientation="portrait"><media xlink:href="jm5c01558_si_001.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="sifile2" position="float" content-type="local-data" orientation="portrait"><media xlink:href="jm5c01558_si_002.csv" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="ACK-d14e3555-autogenerated"><p>Authors D.E.-G. and C.P.-I. thank Ministerio de Ciencia, Innovaci&#243;n
y Universidades and FEDER (Grant PID2022-138335NB-I00) and Xunta de
Galicia (ED431C 2023/33) for generous financial support. A.F.-G. thanks
Ministerio de Universidades (Grant FPU21/06305) for funding her Ph.D
contract. L.V. and S.A.-O. are indebted to CACTI (Universidade de
Vigo) for X-ray measurements. Part of the artwork shown in the Table
of Contents graphic was adapted from pictures provided by Servier
Medical Art licensed under a Creative Commons Attribution 4.0 International
License. The project was granted by the Hungarian National Research
Development and Innovation Office (NKFIH K-134694 (Gy.T.)) and supported
by Program for Scientific Publication of University of Debrecen. F.W.
thanks the New Frontiers in Research Fund (grant NFRFT-2022-00269)
and the Dianne and Irving Kipnes Foundation for supporting this work.
Funding for open access was provided by Universidade da Coruna/CISUG.</p></ack><notes id="notes-2" notes-type="si"><p>The Supporting Information
is available free of charge at <ext-link xlink:href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c01558?goto=supporting-info" ext-link-type="uri">https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c01558</ext-link>.<list list-type="simple" id="silist"><list-item><p>NMR spectra and data,
potentiometric curves, speciation
diagrams, mass spectra, HPLC conditions and traces, additional radiolabeling
data and crystallographic data (<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_001.pdf" ext-link-type="uri">PDF</ext-link>)</p></list-item><list-item><p>Compound names, molecular formula strings
(<ext-link xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.5c01558/suppl_file/jm5c01558_si_002.csv" ext-link-type="uri">CSV</ext-link>)</p></list-item></list>
</p></notes><notes id="notes-1" notes-type="author-contributions"><label>#</label><p>A.F.-G. and Y.B.A.
contributed equally to this work. The manuscript
was written through contributions of all authors. All authors have
given approval to the final version of the manuscript.</p></notes><notes id="NOTES-d14e3576-autogenerated" notes-type="conflict-of-interest"><p>The authors declare no
competing financial interest.</p></notes><notes id="NOTES-d14e3578-autogenerated" notes-type="dedication"><p>This paper is dedicated to Prof.
Ern&#337; Br&#252;cher on the occasion of his 90th birthday.</p></notes><glossary><def-list specific-use="delimiter-char:, " id="dl1"><title>Abreviations Used</title><def-item><term>H<sub>4</sub>CDTA</term><def><p>2,2&#8242;,2&#8243;,2&#8244;-((<italic toggle="yes">trans</italic>-cyclohexane-1,2-diyl)&#173;bis&#173;(azanetriyl))&#173;tetraacetic
acid</p></def></def-item><def-item><term>H<sub>4</sub>
<italic toggle="yes">CHX</italic>OCTAPA</term><def><p>6,6&#8242;-((((1<italic toggle="yes">R</italic>,2<italic toggle="yes">S</italic>)-cyclohexane-1,2-diyl)&#173;bis&#173;((carboxymethyl)&#173;azanediyl))&#173;bis&#173;(methylene))&#173;dipicolinic
acid</p></def></def-item><def-item><term>CR</term><def><p>crystal
radius</p></def></def-item><def-item><term>DAD</term><def><p>diode
array detector</p></def></def-item><def-item><term>DiAmSar</term><def><p>3,6,10,13,16,19-hexaazabicyclo&#173;[6.6.6]&#173;icosane-1,8-diamine</p></def></def-item><def-item><term>DMP</term><def><p>dimethylpiperazine</p></def></def-item><def-item><term>H<sub>3</sub>DO3A</term><def><p>1,4,7,10-tetrazacyclononane-1,4,7-triacetic
acid</p></def></def-item><def-item><term>H<sub>4</sub>DO3Apic</term><def><p>2,2&#8242;,2&#8243;-(10-((6-carboxypyridin-2-yl)&#173;methyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)&#173;triacetic
acid</p></def></def-item><def-item><term>H<sub>4</sub>DOTA</term><def><p>1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid</p></def></def-item><def-item><term>H<sub>5</sub>DTPA</term><def><p>diethylenetriamine-<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>&#8242;,<italic toggle="yes">N</italic>&#8243;,<italic toggle="yes">N</italic>&#8243;-pentaacetic acid</p></def></def-item><def-item><term>H<sub>4</sub>EDTA</term><def><p>ethylenediamine-<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>&#8242;,<italic toggle="yes">N</italic>&#8242;-tetraacetic acid</p></def></def-item><def-item><term>H<sub>2</sub>MACROPA</term><def><p>
<italic toggle="yes">N</italic>,<italic toggle="yes">N</italic>&#8217;-bis&#173;[(6-carboxy-2-pyridil)&#173;methyl]-4,13-diaza-18-crown-6</p></def></def-item><def-item><term>MPLC,</term><def><p>medium performance
liquid chromatography</p></def></def-item><def-item><term>H<sub>3</sub>NOTA</term><def><p>2,2&#8242;,2&#8243;-(1,4,7-triazonane-1,4,7-triyl)&#173;triacetic
acid</p></def></def-item><def-item><term>H<sub>4</sub>OCTAPA</term><def><p>6,6&#8242;-((ethane-1,2-diylbis&#173;((carboxymethyl)&#173;azanediyl))&#173;bis&#173;(methylene))&#173;dipicolinic
acid</p></def></def-item><def-item><term>H<sub>4</sub>PYTA</term><def><p>2,2&#8242;,2&#8243;,2&#8244;-(3,6,10,13-tetraaza-1,8&#173;(2,6)-dipyridinacyclotetradecaphane-3,6,10,13-tetrayl)&#173;tetraacetic
acid</p></def></def-item><def-item><term>H<sub>4</sub>TETA</term><def><p>1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid</p></def></def-item><def-item><term>H<sub>4</sub>TPADAC</term><def><p>(1<italic toggle="yes">R</italic>,2<italic toggle="yes">R</italic>)-<italic toggle="yes">N,N,N&#8242;</italic>,<italic toggle="yes">N</italic>&#8242;-tetrakis&#173;[6-carboxypyridin-2-yl)&#173;methyl]&#173;diaminocyclohexane</p></def></def-item><def-item><term>H<sub>4</sub>TPAEN</term><def><p>
<italic toggle="yes">N,N,N&#8242;N&#8242;</italic>-tetrakis&#173;[(6-carboxypyridin-2-yl)&#173;methyl]-ethylenediamine</p></def></def-item></def-list></glossary><ref-list><ref id="ref1"><element-citation publication-type="journal" id="cit1"><name name-style="western"><surname>Aluicio-Sarduy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Thiele</surname><given-names>N. A.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>K. E.</given-names></name><name name-style="western"><surname>Vaughn</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>Devaraj</surname><given-names>J.</given-names></name><name name-style="western"><surname>Olson</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>Barnhart</surname><given-names>T. E.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Boros</surname><given-names>E.</given-names></name><name name-style="western"><surname>Engle</surname><given-names>J. W.</given-names></name><article-title>Establishing Radiolanthanum
Chemistry for Targeted
Nuclear Medicine Applications</article-title><source>Chem. - Eur.
J.</source><year>2020</year><volume>26</volume><issue>6</issue><fpage>1238</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1002/chem.201905202</pub-id><pub-id pub-id-type="pmid">31743504</pub-id><pub-id pub-id-type="pmcid">PMC7261199</pub-id></element-citation></ref><ref id="ref2"><element-citation publication-type="journal" id="cit2"><name name-style="western"><surname>Nelson</surname><given-names>B. J. B.</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Wuest</surname><given-names>F.</given-names></name><article-title>Radiolanthanum: Promising Theranostic
Radionuclides for PET, Alpha, and Auger-Meitner Therapy</article-title><source>Nucl. Med. Biol.</source><year>2022</year><volume>110&#8211;111</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.nucmedbio.2022.04.005</pub-id><pub-id pub-id-type="pmid">35487834</pub-id></element-citation></ref><ref id="ref3"><element-citation publication-type="journal" id="cit3"><name name-style="western"><surname>Aluicio-Sarduy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Olson</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>Barnhart</surname><given-names>T. E.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ellison</surname><given-names>P. A.</given-names></name><name name-style="western"><surname>Engle</surname><given-names>J. W.</given-names></name><article-title>Production and in Vivo PET/CT Imaging
of the Theranostic Pair <sup>132/135</sup>La</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><issue>1</issue><elocation-id>10658</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-47137-0</pub-id><pub-id pub-id-type="pmid">31337833</pub-id><pub-id pub-id-type="pmcid">PMC6650468</pub-id></element-citation></ref><ref id="ref4"><element-citation publication-type="journal" id="cit4"><name name-style="western"><surname>Br&#252;hlmann</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Walther</surname><given-names>M.</given-names></name><name name-style="western"><surname>Blei</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Mamat</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kopka</surname><given-names>K.</given-names></name><name name-style="western"><surname>Freudenberg</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kreller</surname><given-names>M.</given-names></name><article-title>Scalability Study on
[<sup>133</sup>La]&#173;LaCl<sub>3</sub> Production with a Focus on Potential
Clinical
Applications</article-title><source>EJNMMI Radiopharm. Chem.</source><year>2024</year><volume>9</volume><issue>1</issue><elocation-id>60</elocation-id><pub-id pub-id-type="doi">10.1186/s41181-024-00292-w</pub-id><pub-id pub-id-type="pmid">39147960</pub-id><pub-id pub-id-type="pmcid">PMC11327230</pub-id></element-citation></ref><ref id="ref5"><element-citation publication-type="journal" id="cit5"><name name-style="western"><surname>Br&#252;hlmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kreller</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pietzsch</surname><given-names>H.-J.</given-names></name><name name-style="western"><surname>Kopka</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mamat</surname><given-names>C.</given-names></name><name name-style="western"><surname>Walther</surname><given-names>M.</given-names></name><name name-style="western"><surname>Reissig</surname><given-names>F.</given-names></name><article-title>Efficient
Production of the PET Radionuclide <sup>133</sup>La for Theranostic
Purposes in Targeted Alpha Therapy Using
the <sup>134</sup>Ba&#173;(p,2n)<sup>133</sup>La Reaction</article-title><source>Pharmaceuticals</source><year>2022</year><volume>15</volume><issue>10</issue><fpage>1167</fpage><pub-id pub-id-type="doi">10.3390/ph15101167</pub-id><pub-id pub-id-type="pmid">36297279</pub-id><pub-id pub-id-type="pmcid">PMC9611457</pub-id></element-citation></ref><ref id="ref6"><element-citation publication-type="journal" id="cit6"><name name-style="western"><surname>Chakravarty</surname><given-names>R.</given-names></name><name name-style="western"><surname>Patra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jagadeesan</surname><given-names>K. C.</given-names></name><name name-style="western"><surname>Thakare</surname><given-names>S. V.</given-names></name><name name-style="western"><surname>Chakraborty</surname><given-names>S.</given-names></name><article-title>Electrochemical
Separation of <sup>132/135</sup>La Theranostic Pair from Proton Irradiated
Ba Target</article-title><source>Sep. Purif. Technol.</source><year>2022</year><volume>280</volume><elocation-id>119908</elocation-id><pub-id pub-id-type="doi">10.1016/j.seppur.2021.119908</pub-id></element-citation></ref><ref id="ref7"><element-citation publication-type="journal" id="cit7"><name name-style="western"><surname>Nelson</surname><given-names>B. J. B.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Wuest</surname><given-names>F.</given-names></name><article-title>Theranostic Imaging
Surrogates for Targeted Alpha Therapy: Progress in Production, Purification,
and Applications</article-title><source>Pharmaceuticals</source><year>2023</year><volume>16</volume><issue>11</issue><fpage>1622</fpage><pub-id pub-id-type="doi">10.3390/ph16111622</pub-id><pub-id pub-id-type="pmid">38004486</pub-id><pub-id pub-id-type="pmcid">PMC10674391</pub-id></element-citation></ref><ref id="ref8"><element-citation publication-type="journal" id="cit8"><name name-style="western"><surname>Abel</surname><given-names>E. P.</given-names></name><name name-style="western"><surname>Clause</surname><given-names>H. K.</given-names></name><name name-style="western"><surname>Fonslet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nickles</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Severin</surname><given-names>G. W.</given-names></name><article-title>Half-Lives
of <sup>132</sup>La and <sup>135</sup>La</article-title><source>Phys.
Rev. C</source><year>2018</year><volume>97</volume><issue>3</issue><elocation-id>034312</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevC.97.034312</pub-id></element-citation></ref><ref id="ref9"><element-citation publication-type="journal" id="cit9"><name name-style="western"><surname>Gehrke</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Helmer</surname><given-names>R. G.</given-names></name><article-title>Half-Lives of <sup>134</sup>La and <sup>132&#8211;135</sup>Ce</article-title><source>J. Inorg. Nucl. Chem.</source><year>1976</year><volume>38</volume><issue>11</issue><fpage>1929</fpage><lpage>1932</lpage><pub-id pub-id-type="doi">10.1016/0022-1902(76)80440-X</pub-id></element-citation></ref><ref id="ref10"><element-citation publication-type="journal" id="cit10"><name name-style="western"><surname>Bailey</surname><given-names>T. A.</given-names></name><name name-style="western"><surname>Mocko</surname><given-names>V.</given-names></name><name name-style="western"><surname>Shield</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>An</surname><given-names>D. D.</given-names></name><name name-style="western"><surname>Akin</surname><given-names>A. C.</given-names></name><name name-style="western"><surname>Birnbaum</surname><given-names>E. R.</given-names></name><name name-style="western"><surname>Brugh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cooley</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Engle</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Fassbender</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Gauny</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Lakes</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Nortier</surname><given-names>F. M.</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>E. M.</given-names></name><name name-style="western"><surname>Thiemann</surname><given-names>S. L.</given-names></name><name name-style="western"><surname>White</surname><given-names>F. D.</given-names></name><name name-style="western"><surname>Vermeulen</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kozimor</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Abergel</surname><given-names>R. J.</given-names></name><article-title>Developing the 134Ce and 134La Pair
as Companion Positron Emission Tomography Diagnostic Isotopes for
225Ac and 227Th Radiotherapeutics</article-title><source>Nat. Chem.</source><year>2021</year><volume>13</volume><issue>3</issue><fpage>284</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1038/s41557-020-00598-7</pub-id><pub-id pub-id-type="pmid">33318671</pub-id></element-citation></ref><ref id="ref11"><element-citation publication-type="journal" id="cit11"><name name-style="western"><surname>Nelson</surname><given-names>B. J. B.</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wuest</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Duke</surname><given-names>M. J. M.</given-names></name><name name-style="western"><surname>Richter</surname><given-names>S.</given-names></name><name name-style="western"><surname>Soenke-Jans</surname><given-names>H.</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Juengling</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wuest</surname><given-names>F.</given-names></name><article-title>First In Vivo and Phantom Imaging
of Cyclotron-Produced <sup>133</sup>La as a Theranostic Radionuclide
for <sup>225</sup>Ac and <sup>135</sup>La</article-title><source>J.
Nucl. Med.</source><year>2022</year><volume>63</volume><issue>4</issue><fpage>584</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.2967/jnumed.121.262459</pub-id><pub-id pub-id-type="pmid">34385334</pub-id><pub-id pub-id-type="pmcid">PMC8973294</pub-id></element-citation></ref><ref id="ref12"><element-citation publication-type="journal" id="cit12"><name name-style="western"><surname>Fonslet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>B. Q.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>T. A.</given-names></name><name name-style="western"><surname>Siragusa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kib&#233;di</surname><given-names>T.</given-names></name><name name-style="western"><surname>Stuchbery</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Severin</surname><given-names>G. W.</given-names></name><article-title>
<sup>135</sup>La
as an Auger-Electron Emitter for Targeted Internal Radiotherapy</article-title><source>Phys. Med. Biol.</source><year>2018</year><volume>63</volume><issue>1</issue><elocation-id>015026</elocation-id><pub-id pub-id-type="doi">10.1088/1361-6560/aa9b44</pub-id><pub-id pub-id-type="pmid">29286003</pub-id></element-citation></ref><ref id="ref13"><element-citation publication-type="journal" id="cit13"><name name-style="western"><surname>Hindi&#233;</surname><given-names>E.</given-names></name><name name-style="western"><surname>K&#246;ster</surname><given-names>U.</given-names></name><name name-style="western"><surname>Champion</surname><given-names>C.</given-names></name><name name-style="western"><surname>Zanotti-Fregonara</surname><given-names>P.</given-names></name><name name-style="western"><surname>Morgat</surname><given-names>C.</given-names></name><article-title>Comparative Analysis
of Positron Emitters for Theranostic
Applications Based on Small Bioconjugates Highlighting <sup>43</sup>Sc, <sup>61</sup>Cu and <sup>45</sup>Ti</article-title><source>EJNMMI
Phys.</source><year>2024</year><volume>11</volume><issue>1</issue><elocation-id>98</elocation-id><pub-id pub-id-type="doi">10.1186/s40658-024-00699-z</pub-id><pub-id pub-id-type="pmid">39572444</pub-id><pub-id pub-id-type="pmcid">PMC11582248</pub-id></element-citation></ref><ref id="ref14"><element-citation publication-type="journal" id="cit14"><name name-style="western"><surname>Sadler</surname><given-names>A. W. E.</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>L.</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rendina</surname><given-names>L. M.</given-names></name><article-title>Cutting
Edge Rare
Earth Radiometals: Prospects for Cancer Theranostics</article-title><source>EJNMMI Radiopharm. Chem.</source><year>2022</year><volume>7</volume><issue>1</issue><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1186/s41181-022-00173-0</pub-id><pub-id pub-id-type="pmid">36018527</pub-id><pub-id pub-id-type="pmcid">PMC9418400</pub-id></element-citation></ref><ref id="ref15"><element-citation publication-type="journal" id="cit15"><name name-style="western"><surname>Aluicio-Sarduy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Barnhart</surname><given-names>T. E.</given-names></name><name name-style="western"><surname>Weichert</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Engle</surname><given-names>J. W.</given-names></name><article-title>Cyclotron-Produced <sup>132</sup>La as a PET Imaging
Surrogate for Therapeutic <sup>225</sup>Ac</article-title><source>J. Nucl. Med.</source><year>2021</year><volume>62</volume><issue>7</issue><fpage>1012</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.2967/jnumed.120.255794</pub-id><pub-id pub-id-type="pmid">33127622</pub-id><pub-id pub-id-type="pmcid">PMC8882879</pub-id></element-citation></ref><ref id="ref16"><element-citation publication-type="journal" id="cit16"><name name-style="western"><surname>Singh</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rodionov</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Khazov</surname><given-names>Y. L.</given-names></name><article-title>Nuclear
Data Sheets for A = 135</article-title><source>Nucl. Data Sheets</source><year>2008</year><volume>109</volume><issue>3</issue><fpage>517</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1016/j.nds.2008.02.001</pub-id></element-citation></ref><ref id="ref17"><element-citation publication-type="journal" id="cit17"><name name-style="western"><surname>Pearson</surname><given-names>R. G.</given-names></name><article-title>Absolute
Electronegativity and Hardness: Application to Inorganic Chemistry</article-title><source>Inorg. Chem.</source><year>1988</year><volume>27</volume><issue>4</issue><fpage>734</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1021/ic00277a030</pub-id></element-citation></ref><ref id="ref18"><element-citation publication-type="journal" id="cit18"><name name-style="western"><surname>Parr</surname><given-names>R. G.</given-names></name><name name-style="western"><surname>Pearson</surname><given-names>R. G.</given-names></name><article-title>Absolute Hardness: Companion Parameter to Absolute
Electronegativity</article-title><source>J. Am. Chem. Soc.</source><year>1983</year><volume>105</volume><issue>26</issue><fpage>7512</fpage><lpage>7516</lpage><pub-id pub-id-type="doi">10.1021/ja00364a005</pub-id></element-citation></ref><ref id="ref19"><element-citation publication-type="journal" id="cit19"><name name-style="western"><surname>Cotton</surname><given-names>S. A.</given-names></name><article-title>Establishing
Coordination Numbers for the Lanthanides in Simple Complexes</article-title><source>Comptes Rendus Chim.</source><year>2005</year><volume>8</volume><issue>2</issue><fpage>129</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.crci.2004.07.002</pub-id></element-citation></ref><ref id="ref20"><element-citation publication-type="journal" id="cit20"><name name-style="western"><surname>Cotton</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Raithby</surname><given-names>P. R.</given-names></name><article-title>Systematics and
Surprises in Lanthanide Coordination
Chemistry</article-title><source>Coord. Chem. Rev.</source><year>2017</year><volume>340</volume><fpage>220</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2017.01.011</pub-id></element-citation></ref><ref id="ref21"><element-citation publication-type="journal" id="cit21"><name name-style="western"><surname>Stasiuk</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Long</surname><given-names>N. J.</given-names></name><article-title>The Ubiquitous DOTA
and Its Derivatives: The Impact
of 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid on Biomedical
Imaging</article-title><source>Chem. Commun.</source><year>2013</year><volume>49</volume><issue>27</issue><fpage>2732</fpage><pub-id pub-id-type="doi">10.1039/c3cc38507h</pub-id><pub-id pub-id-type="pmid">23392443</pub-id></element-citation></ref><ref id="ref22"><element-citation publication-type="journal" id="cit22"><name name-style="western"><surname>Kostelnik</surname><given-names>T. I.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><article-title>Radioactive Main Group
and Rare Earth Metals for Imaging and Therapy</article-title><source>Chem. Rev.</source><year>2019</year><volume>119</volume><issue>2</issue><fpage>902</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00294</pub-id><pub-id pub-id-type="pmid">30379537</pub-id></element-citation></ref><ref id="ref23"><element-citation publication-type="journal" id="cit23"><name name-style="western"><surname>Br&#252;cher</surname><given-names>E.</given-names></name><name name-style="western"><surname>Laurenczy</surname><given-names>G.</given-names></name><name name-style="western"><surname>Makra</surname><given-names>Z. S.</given-names></name><article-title>Studies on the Kinetics
of Formation
and Dissociation of the Cerium&#173;(III)-DOTA Complex</article-title><source>Inorg. Chim. Acta</source><year>1987</year><volume>139</volume><issue>1&#8211;2</issue><fpage>141</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/S0020-1693(00)84060-8</pub-id></element-citation></ref><ref id="ref24"><element-citation publication-type="journal" id="cit24"><name name-style="western"><surname>Toth</surname><given-names>E.</given-names></name><name name-style="western"><surname>Brucher</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lazar</surname><given-names>I.</given-names></name><name name-style="western"><surname>Toth</surname><given-names>I.</given-names></name><article-title>Kinetics of Formation
and Dissociation of Lanthanide&#173;(III)-DOTA Complexes</article-title><source>Inorg. Chem.</source><year>1994</year><volume>33</volume><issue>18</issue><fpage>4070</fpage><lpage>4076</lpage><pub-id pub-id-type="doi">10.1021/ic00096a036</pub-id></element-citation></ref><ref id="ref25"><element-citation publication-type="journal" id="cit25"><name name-style="western"><surname>Shannon</surname><given-names>R. D.</given-names></name><article-title>Revised
Effective Ionic Radii and Systematic Studies of Interatomic Distances
in Halides and Chaleogenides</article-title><source>Acta Crystallogr.
A</source><year>1976</year><volume>32</volume><fpage>751</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1107/S0567739476001551</pub-id></element-citation></ref><ref id="ref26"><element-citation publication-type="journal" id="cit26"><name name-style="western"><surname>Hu</surname><given-names>A.</given-names></name><name name-style="western"><surname>MacMillan</surname><given-names>S. N.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J. J.</given-names></name><article-title>Macrocyclic Ligands with an Unprecedented
Size-Selectivity Pattern for the Lanthanide Ions</article-title><source>J. Am. Chem. Soc.</source><year>2020</year><volume>142</volume><issue>31</issue><fpage>13500</fpage><lpage>13506</lpage><pub-id pub-id-type="doi">10.1021/jacs.0c05217</pub-id><pub-id pub-id-type="pmid">32697907</pub-id><pub-id pub-id-type="pmcid">PMC8084257</pub-id></element-citation></ref><ref id="ref27"><element-citation publication-type="journal" id="cit27"><name name-style="western"><surname>Thiele</surname><given-names>N. A.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Amor-Coarasa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jermilova</surname><given-names>U.</given-names></name><name name-style="western"><surname>MacMillan</surname><given-names>S. N.</given-names></name><name name-style="western"><surname>Nikolopoulou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ponnala</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ramogida</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>A. K. H.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Rodr&#237;guez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Schaffer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>C.</given-names></name><name name-style="western"><surname>Babich</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Radchenko</surname><given-names>V.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>J. J.</given-names></name><article-title>An Eighteen-Membered
Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy</article-title><source>Angew. Chem., Int. Ed.</source><year>2017</year><volume>56</volume><issue>46</issue><fpage>14712</fpage><lpage>14717</lpage><pub-id pub-id-type="doi">10.1002/anie.201709532</pub-id><pub-id pub-id-type="pmid">28963750</pub-id></element-citation></ref><ref id="ref28"><element-citation publication-type="journal" id="cit28"><name name-style="western"><surname>Valencia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mac&#237;as</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bastida</surname><given-names>R.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>R. A.</given-names></name><name name-style="western"><surname>Geraldes</surname><given-names>C. F. G. C.</given-names></name><article-title>X-Ray Diffraction
and <sup>1</sup>H NMR in Solution:
Structural Determination of Lanthanide Complexes of a Py<sub>2</sub>N<sub>6</sub>Ac<sub>4</sub> Ligand</article-title><source>Inorg.
Chem.</source><year>2002</year><volume>41</volume><issue>20</issue><fpage>5300</fpage><lpage>5312</lpage><pub-id pub-id-type="doi">10.1021/ic0257017</pub-id><pub-id pub-id-type="pmid">12354065</pub-id></element-citation></ref><ref id="ref29"><element-citation publication-type="journal" id="cit29"><name name-style="western"><surname>Amin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morrow</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Lake</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Churchill</surname><given-names>M. R.</given-names></name><article-title>Lanthanide&#173;(III)
Tetraamide Macrocyclic Complexes as Synthetic Ribonucleases: Structure
and Catalytic Properties of [La&#173;(Tcmc)&#173;(CF<sub>3</sub>SO<sub>3</sub>)&#173;(EtOH)]&#173;(CF<sub>3</sub>SO<sub>3</sub>)<sub>2</sub>
</article-title><source>Angew. Chem., Int. Ed.</source><year>1994</year><volume>33</volume><issue>7</issue><fpage>773</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1002/anie.199407731</pub-id></element-citation></ref><ref id="ref30"><element-citation publication-type="journal" id="cit30"><name name-style="western"><surname>Laus</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ruloff</surname><given-names>R.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Merbach</surname><given-names>A. E.</given-names></name><article-title>Gd<sup>III</sup> Complexes with Fast Water Exchange
and High Thermodynamic Stability:
Potential Building Blocks for High-Relaxivity MRI Contrast Agents</article-title><source>Chem. - Eur. J.</source><year>2003</year><volume>9</volume><issue>15</issue><fpage>3555</fpage><lpage>3566</lpage><pub-id pub-id-type="doi">10.1002/chem.200204612</pub-id><pub-id pub-id-type="pmid">12898682</pub-id></element-citation></ref><ref id="ref31"><element-citation publication-type="journal" id="cit31"><name name-style="western"><surname>Simms</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sibley</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Ivanov</surname><given-names>A. S.</given-names></name><name name-style="western"><surname>Lara</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Johnstone</surname><given-names>T. C.</given-names></name><name name-style="western"><surname>Kertesz</surname><given-names>V.</given-names></name><name name-style="western"><surname>Fears</surname><given-names>A.</given-names></name><name name-style="western"><surname>White</surname><given-names>F. D.</given-names></name><name name-style="western"><surname>Thorek</surname><given-names>D. L. J.</given-names></name><name name-style="western"><surname>Thiele</surname><given-names>N. A.</given-names></name><article-title>PYTA: A Universal Chelator for Advancing the Theranostic
Palette of Nuclear Medicine</article-title><source>Chem. Sci.</source><year>2024</year><volume>15</volume><issue>29</issue><fpage>11279</fpage><lpage>11286</lpage><pub-id pub-id-type="doi">10.1039/D3SC06854D</pub-id><pub-id pub-id-type="pmid">39055008</pub-id><pub-id pub-id-type="pmcid">PMC11268510</pub-id></element-citation></ref><ref id="ref32"><mixed-citation publication-type="other" id="cit32"><person-group person-group-type="allauthors"><string-name name-style="western"><surname>Sullivan</surname>, <given-names>B.</given-names></string-name>; <string-name name-style="western"><surname>Davis</surname>, <given-names>A.</given-names></string-name>; <string-name name-style="western"><surname>Bak</surname>, <given-names>P.</given-names></string-name></person-group><article-title>The
Radiopharmaceutical Renaissance:
Radiating Hope in Cancer Therapy</article-title><source>Biopharma
Deal</source><year>2024</year><pub-id pub-id-type="doi">10.1038/d43747-024-00014-w</pub-id>.</mixed-citation></ref><ref id="ref33"><element-citation publication-type="journal" id="cit33"><name name-style="western"><surname>Jaraquemada-Pel&#225;ez</surname><given-names>M. d. G.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Clough</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Choudhary</surname><given-names>N.</given-names></name><name name-style="western"><surname>Emler</surname><given-names>K.</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>B. O.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><article-title>H<sub>4</sub>Octapa:
Synthesis, Solution Equilibria and Complexes with Useful Radiopharmaceutical
Metal Ions</article-title><source>Dalton Trans.</source><year>2017</year><volume>46</volume><issue>42</issue><fpage>14647</fpage><lpage>14658</lpage><pub-id pub-id-type="doi">10.1039/C7DT02343J</pub-id><pub-id pub-id-type="pmid">28853751</pub-id></element-citation></ref><ref id="ref34"><element-citation publication-type="journal" id="cit34"><name name-style="western"><surname>Ramogida</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>Cawthray</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Boros</surname><given-names>E.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>B. O.</given-names></name><name name-style="western"><surname>Adam</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><article-title>H<sub>2</sub>
<italic toggle="yes">CHX</italic>Dedpa and H<sub>4</sub>
<italic toggle="yes">CHX</italic>Octapa&#58872;Chiral
Acyclic
Chelating Ligands for <sup>67/68</sup>Ga and <sup>111</sup>In Radiopharmaceuticals</article-title><source>Inorg. Chem.</source><year>2015</year><volume>54</volume><issue>4</issue><fpage>2017</fpage><lpage>2031</lpage><pub-id pub-id-type="doi">10.1021/ic502942a</pub-id><pub-id pub-id-type="pmid">25621728</pub-id></element-citation></ref><ref id="ref35"><element-citation publication-type="journal" id="cit35"><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>H.-T.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Merkens</surname><given-names>H.</given-names></name><name name-style="western"><surname>Colpo</surname><given-names>N.</given-names></name><name name-style="western"><surname>Radchenko</surname><given-names>V.</given-names></name><name name-style="western"><surname>Schaffer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>K.-S.</given-names></name><name name-style="western"><surname>B&#233;nard</surname><given-names>F.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><article-title>
<sup>t</sup>Bu<sub>4</sub>Octapa-Alkyl-NHS for Metalloradiopeptide
Preparation</article-title><source>Dalton Trans.</source><year>2020</year><volume>49</volume><issue>22</issue><fpage>7605</fpage><lpage>7619</lpage><pub-id pub-id-type="doi">10.1039/D0DT00845A</pub-id><pub-id pub-id-type="pmid">32459231</pub-id></element-citation></ref><ref id="ref36"><element-citation publication-type="journal" id="cit36"><name name-style="western"><surname>Price</surname><given-names>E. W.</given-names></name><name name-style="western"><surname>Zeglis</surname><given-names>B. M.</given-names></name><name name-style="western"><surname>Cawthray</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Ramogida</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Adam</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><article-title>H<sub>4</sub>Octapa-Trastuzumab:
Versatile Acyclic Chelate System for <sup>111</sup>In and <sup>177</sup>Lu Imaging and Therapy</article-title><source>J. Am. Chem. Soc.</source><year>2013</year><volume>135</volume><issue>34</issue><fpage>12707</fpage><lpage>12721</lpage><pub-id pub-id-type="doi">10.1021/ja4049493</pub-id><pub-id pub-id-type="pmid">23901833</pub-id><pub-id pub-id-type="pmcid">PMC3787943</pub-id></element-citation></ref><ref id="ref37"><element-citation publication-type="journal" id="cit37"><name name-style="western"><surname>Price</surname><given-names>E. W.</given-names></name><name name-style="western"><surname>Cawthray</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Boros</surname><given-names>E.</given-names></name><name name-style="western"><surname>Adam</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><article-title>H<sub>4</sub>Octapa: An Acyclic Chelator
for <sup>111</sup>In Radiopharmaceuticals</article-title><source>J.
Am. Chem. Soc.</source><year>2012</year><volume>134</volume><issue>20</issue><fpage>8670</fpage><lpage>8683</lpage><pub-id pub-id-type="doi">10.1021/ja3024725</pub-id><pub-id pub-id-type="pmid">22540281</pub-id></element-citation></ref><ref id="ref38"><element-citation publication-type="journal" id="cit38"><name name-style="western"><surname>Price</surname><given-names>E. W.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>K. J.</given-names></name><name name-style="western"><surname>Carnazza</surname><given-names>K. E.</given-names></name><name name-style="western"><surname>Carlin</surname><given-names>S. D.</given-names></name><name name-style="western"><surname>Zeglis</surname><given-names>B. M.</given-names></name><name name-style="western"><surname>Adam</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>J. S.</given-names></name><article-title>A Comparative Evaluation
of the Chelators H<sub>4</sub>Octapa and CHX-A&#8243;-DTPA with the
Therapeutic Radiometal <sup>90</sup>Y</article-title><source>Nucl.
Med. Biol.</source><year>2016</year><volume>43</volume><issue>9</issue><fpage>566</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1016/j.nucmedbio.2016.06.004</pub-id><pub-id pub-id-type="pmid">27419360</pub-id><pub-id pub-id-type="pmcid">PMC4992617</pub-id></element-citation></ref><ref id="ref39"><element-citation publication-type="journal" id="cit39"><name name-style="western"><surname>Lucio-Mart&#237;nez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Garda</surname><given-names>Z.</given-names></name><name name-style="western"><surname>V&#225;radi</surname><given-names>B.</given-names></name><name name-style="western"><surname>K&#225;lm&#225;n</surname><given-names>F. K.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Tircs&#243;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><article-title>Rigidified
Derivative of the Non-Macrocyclic Ligand
H<sub>4</sub>OCTAPA for Stable Lanthanide&#173;(III) Complexation</article-title><source>Inorg. Chem.</source><year>2022</year><volume>61</volume><issue>12</issue><fpage>5157</fpage><lpage>5171</lpage><pub-id pub-id-type="doi">10.1021/acs.inorgchem.2c00501</pub-id><pub-id pub-id-type="pmid">35275621</pub-id><pub-id pub-id-type="pmcid">PMC8965877</pub-id></element-citation></ref><ref id="ref40"><element-citation publication-type="journal" id="cit40"><name name-style="western"><surname>Tircs&#243;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Regueiro-Figueroa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>V.</given-names></name><name name-style="western"><surname>Garda</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Garai</surname><given-names>T.</given-names></name><name name-style="western"><surname>K&#225;lm&#225;n</surname><given-names>F. K.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><article-title>Approaching
the Kinetic Inertness
of Macrocyclic Gadolinium&#173;(III)-Based MRI Contrast Agents with Highly
Rigid Open-Chain Derivatives</article-title><source>Chem. - Eur. J.</source><year>2016</year><volume>22</volume><issue>3</issue><fpage>896</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1002/chem.201503836</pub-id><pub-id pub-id-type="pmid">26583317</pub-id></element-citation></ref><ref id="ref41"><element-citation publication-type="journal" id="cit41"><name name-style="western"><surname>Chatterton</surname><given-names>N.</given-names></name><name name-style="western"><surname>Bretonni&#232;re</surname><given-names>Y.</given-names></name><name name-style="western"><surname>P&#233;caut</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mazzanti</surname><given-names>M.</given-names></name><article-title>An Efficient Design
for the Rigid Assembly of Four Bidentate Chromophores in Water-Stable
Highly Luminescent Lanthanide Complexes</article-title><source>Angew.
Chem., Int. Ed.</source><year>2005</year><volume>44</volume><issue>46</issue><fpage>7595</fpage><lpage>7598</lpage><pub-id pub-id-type="doi">10.1002/anie.200502231</pub-id><pub-id pub-id-type="pmid">16302184</pub-id></element-citation></ref><ref id="ref42"><element-citation publication-type="journal" id="cit42"><name name-style="western"><surname>Adewuyi</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Schley</surname><given-names>N. D.</given-names></name><name name-style="western"><surname>Ung</surname><given-names>G.</given-names></name><article-title>Synthesis
of Bright Water-Soluble
Circularly Polarized Luminescence Emitters as Potential Sensors</article-title><source>Inorg. Chem. Front.</source><year>2022</year><volume>9</volume><issue>7</issue><fpage>1474</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1039/D1QI01398J</pub-id></element-citation></ref><ref id="ref43"><element-citation publication-type="journal" id="cit43"><name name-style="western"><surname>K&#225;lm&#225;n</surname><given-names>F. K.</given-names></name><name name-style="western"><surname>V&#233;gh</surname><given-names>A.</given-names></name><name name-style="western"><surname>Regueiro-Figueroa</surname><given-names>M.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tircs&#243;</surname><given-names>G.</given-names></name><article-title>H<sub>4</sub>Octapa: Highly Stable Complexation of
Lanthanide&#173;(III) Ions and Copper&#173;(II)</article-title><source>Inorg.
Chem.</source><year>2015</year><volume>54</volume><issue>5</issue><fpage>2345</fpage><lpage>2356</lpage><pub-id pub-id-type="doi">10.1021/ic502966m</pub-id><pub-id pub-id-type="pmid">25692564</pub-id></element-citation></ref><ref id="ref44"><element-citation publication-type="journal" id="cit44"><name name-style="western"><surname>Chatterton</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gateau</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mazzanti</surname><given-names>M.</given-names></name><name name-style="western"><surname>P&#233;caut</surname><given-names>J.</given-names></name><name name-style="western"><surname>Borel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Helm</surname><given-names>L.</given-names></name><name name-style="western"><surname>Merbach</surname><given-names>A.</given-names></name><article-title>The Effect of Pyridinecarboxylate
Chelating Groups on the Stability and Electronic Relaxation of Gadolinium
Complexes</article-title><source>Dalton Trans</source><year>2005</year><issue>6</issue><fpage>1129</fpage><lpage>1135</lpage><pub-id pub-id-type="doi">10.1039/B416150E</pub-id><pub-id pub-id-type="pmid">15739017</pub-id></element-citation></ref><ref id="ref45"><element-citation publication-type="journal" id="cit45"><name name-style="western"><surname>Hancock</surname><given-names>R. D.</given-names></name><name name-style="western"><surname>Martell</surname><given-names>A. E.</given-names></name><article-title>Ligand Design for
Selective Complexation of Metal Ions
in Aqueous Solution</article-title><source>Chem. Rev.</source><year>1989</year><volume>89</volume><issue>8</issue><fpage>1875</fpage><lpage>1914</lpage><pub-id pub-id-type="doi">10.1021/cr00098a011</pub-id></element-citation></ref><ref id="ref46"><element-citation publication-type="journal" id="cit46"><name name-style="western"><surname>Steimbach</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Tihanyi</surname><given-names>G.</given-names></name><name name-style="western"><surname>G&#233;raldy</surname><given-names>M. N.
E.</given-names></name><name name-style="western"><surname>Wzorek</surname><given-names>A.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Klika</surname><given-names>K. D.</given-names></name><article-title>Can an Intermediate Rate of Nitrogen
Inversion Affect Drug Efficacy?</article-title><source>Symmetry</source><year>2021</year><volume>13</volume><issue>9</issue><fpage>1753</fpage><pub-id pub-id-type="doi">10.3390/sym13091753</pub-id></element-citation></ref><ref id="ref47"><element-citation publication-type="journal" id="cit47"><name name-style="western"><surname>Lambert</surname><given-names>J. B.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>W. L.</given-names></name><name name-style="western"><surname>Packard</surname><given-names>B. S.</given-names></name><article-title>Nitrogen
Inversion in Cyclic N-Chloroamines
and N-Methylamines</article-title><source>J. Am. Chem. Soc.</source><year>1971</year><volume>93</volume><issue>4</issue><fpage>933</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1021/ja00733a025</pub-id></element-citation></ref><ref id="ref48"><element-citation publication-type="journal" id="cit48"><name name-style="western"><surname>Bushweller</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C. Y.</given-names></name><name name-style="western"><surname>Reny</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lourandos</surname><given-names>M. Z.</given-names></name><article-title>The Rotation-Inversion
Dichotomy in Trialkylamines. Direct Proton DNMR Observation of Distinctly
Different Rates of Nitrogen Inversion and Carbon-Nitrogen Bond Rotation
in Isopropylmethylethylamine</article-title><source>J. Am. Chem. Soc.</source><year>1977</year><volume>99</volume><issue>12</issue><fpage>3938</fpage><lpage>3941</lpage><pub-id pub-id-type="doi">10.1021/ja00454a007</pub-id></element-citation></ref><ref id="ref49"><element-citation publication-type="journal" id="cit49"><name name-style="western"><surname>Belostotskii</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Gottlieb</surname><given-names>H. E.</given-names></name><name name-style="western"><surname>Shokhen</surname><given-names>M.</given-names></name><article-title>Nitrogen Inversion in Cyclic Amines
and the Bicyclic Effect</article-title><source>J. Org. Chem.</source><year>2002</year><volume>67</volume><issue>26</issue><fpage>9257</fpage><lpage>9266</lpage><pub-id pub-id-type="doi">10.1021/jo020221i</pub-id><pub-id pub-id-type="pmid">12492327</pub-id></element-citation></ref><ref id="ref50"><element-citation publication-type="journal" id="cit50"><name name-style="western"><surname>Baranyai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>P&#225;link&#225;s</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Uggeri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Br&#252;cher</surname><given-names>E.</given-names></name><article-title>Equilibrium
Studies on the Gd<sup>3+</sup>, Cu<sup>2+</sup> and Zn<sup>2+</sup> Complexes of BOPTA, DTPA and DTPA-BMA Ligands: Kinetics of Metal-Exchange
Reactions of [Gd&#173;(BOPTA)]<sup>2&#8209;</sup>
</article-title><source>Eur. J. Inorg. Chem.</source><year>2010</year><volume>2010</volume><issue>13</issue><fpage>1948</fpage><lpage>1956</lpage><pub-id pub-id-type="doi">10.1002/ejic.200901261</pub-id></element-citation></ref><ref id="ref51"><element-citation publication-type="journal" id="cit51"><name name-style="western"><surname>K&#225;lm&#225;n</surname><given-names>F. K.</given-names></name><name name-style="western"><surname>Tircs&#243;</surname><given-names>G.</given-names></name><article-title>Kinetic Inertness
of the Mn<sup>2+</sup> Complexes
Formed with AAZTA and Some Open-Chain EDTA Derivatives</article-title><source>Inorg. Chem.</source><year>2012</year><volume>51</volume><issue>19</issue><fpage>10065</fpage><lpage>10067</lpage><pub-id pub-id-type="doi">10.1021/ic300832e</pub-id><pub-id pub-id-type="pmid">22974437</pub-id></element-citation></ref><ref id="ref52"><element-citation publication-type="journal" id="cit52"><name name-style="western"><surname>Corey</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>Bailar</surname><given-names>J. C.</given-names></name><article-title>The Stereochemistry
of Complex Inorganic Compounds.
XXII. Stereospecific Effects in Complex Ions <sup>1</sup>
</article-title><source>J. Am. Chem. Soc.</source><year>1959</year><volume>81</volume><issue>11</issue><fpage>2620</fpage><lpage>2629</lpage><pub-id pub-id-type="doi">10.1021/ja01520a006</pub-id></element-citation></ref><ref id="ref53"><element-citation publication-type="journal" id="cit53"><name name-style="western"><surname>Maigut</surname><given-names>J.</given-names></name><name name-style="western"><surname>Meier</surname><given-names>R.</given-names></name><name name-style="western"><surname>Zahl</surname><given-names>A.</given-names></name><name name-style="western"><surname>van Eldik</surname><given-names>R.</given-names></name><article-title>Effect of
Chelate Dynamics on Water Exchange Reactions of Paramagnetic Aminopolycarboxylate
Complexes</article-title><source>Inorg. Chem.</source><year>2008</year><volume>47</volume><issue>13</issue><fpage>5702</fpage><lpage>5719</lpage><pub-id pub-id-type="doi">10.1021/ic702421z</pub-id><pub-id pub-id-type="pmid">18510310</pub-id></element-citation></ref><ref id="ref54"><element-citation publication-type="journal" id="cit54"><name name-style="western"><surname>Beattie</surname><given-names>J. K.</given-names></name><article-title>Conformational
Analysis of Tris&#173;(Ethylenediamine) Complexes</article-title><source>Acc. Chem. Res.</source><year>1971</year><volume>4</volume><issue>7</issue><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1021/ar50043a004</pub-id></element-citation></ref><ref id="ref55"><element-citation publication-type="journal" id="cit55"><name name-style="western"><surname>Regueiro-Figueroa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Barriada</surname><given-names>J. L.</given-names></name><name name-style="western"><surname>Pallier</surname><given-names>A.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Blas</surname><given-names>A. de.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Blas</surname><given-names>T.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><article-title>Stabilizing Divalent Europium in
Aqueous Solution Using Size-Discrimination and Electrostatic Effects</article-title><source>Inorg. Chem.</source><year>2015</year><volume>54</volume><issue>10</issue><fpage>4940</fpage><lpage>4952</lpage><pub-id pub-id-type="doi">10.1021/acs.inorgchem.5b00548</pub-id><pub-id pub-id-type="pmid">25942280</pub-id></element-citation></ref><ref id="ref56"><element-citation publication-type="journal" id="cit56"><name name-style="western"><surname>Weekes</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Ramogida</surname><given-names>C. F.</given-names></name><name name-style="western"><surname>Jaraquemada-Pel&#225;ez</surname><given-names>M. de G.</given-names></name><name name-style="western"><surname>Patrick</surname><given-names>B. O.</given-names></name><name name-style="western"><surname>Apte</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kostelnik</surname><given-names>T. I.</given-names></name><name name-style="western"><surname>Cawthray</surname><given-names>J. F.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>L.</given-names></name><name name-style="western"><surname>Orvig</surname><given-names>C.</given-names></name><article-title>Dipicolinate Complexes
of Gallium&#173;(III) and Lanthanum&#173;(III)</article-title><source>Inorg. Chem.</source><year>2016</year><volume>55</volume><issue>24</issue><fpage>12544</fpage><lpage>12558</lpage><pub-id pub-id-type="doi">10.1021/acs.inorgchem.6b02357</pub-id><pub-id pub-id-type="pmid">27989179</pub-id></element-citation></ref><ref id="ref57"><element-citation publication-type="journal" id="cit57"><name name-style="western"><surname>Bretonni&#232;re</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Mazzanti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pecaut</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dunand</surname><given-names>F. A.</given-names></name><name name-style="western"><surname>Merbach</surname><given-names>E.</given-names></name><article-title>Solid-State
and Solution Properties of the Lanthanide Complexes of a New Heptadentate
Tripodal Ligand: A Route to Gadolinium Complexes with an Improved
Relaxation Efficiency</article-title><source>Inorg. Chem.</source><year>2001</year><volume>40</volume><fpage>6737</fpage><lpage>6745</lpage><pub-id pub-id-type="doi">10.1021/ic010591+</pub-id><pub-id pub-id-type="pmid">11735486</pub-id></element-citation></ref><ref id="ref58"><element-citation publication-type="journal" id="cit58"><name name-style="western"><surname>Baloch</surname><given-names>A. A. B.</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Mumtaz</surname><given-names>F.</given-names></name><name name-style="western"><surname>Muqaibel</surname><given-names>A. H.</given-names></name><name name-style="western"><surname>Rashkeev</surname><given-names>S. N.</given-names></name><name name-style="western"><surname>Alharbi</surname><given-names>F. H.</given-names></name><article-title>Extending
Shannon&#8217;s Ionic Radii Database Using
Machine Learning</article-title><source>Phys. Rev. Mater.</source><year>2021</year><volume>5</volume><issue>4</issue><elocation-id>043804</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevMaterials.5.043804</pub-id></element-citation></ref><ref id="ref59"><element-citation publication-type="journal" id="cit59"><name name-style="western"><surname>Harriswangler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Fr&#237;as</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Albelda</surname><given-names>M. T.</given-names></name><name name-style="western"><surname>Valencia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Garc&#237;a-Espa&#241;a</surname><given-names>E.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><article-title>Donor Radii in Rare-Earth Complexes</article-title><source>Inorg. Chem.</source><year>2023</year><volume>62</volume><issue>41</issue><fpage>17030</fpage><lpage>17040</lpage><pub-id pub-id-type="doi">10.1021/acs.inorgchem.3c03126</pub-id><pub-id pub-id-type="pmid">37782312</pub-id><pub-id pub-id-type="pmcid">PMC10583196</pub-id></element-citation></ref><ref id="ref60"><element-citation publication-type="journal" id="cit60"><name name-style="western"><surname>Harriswangler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Argibay-Otero</surname><given-names>S.</given-names></name><name name-style="western"><surname>Freire-Garc&#237;a</surname><given-names>A.</given-names></name><name name-style="western"><surname>Albelda</surname><given-names>M. T.</given-names></name><name name-style="western"><surname>Garc&#237;a-Espa&#241;a</surname><given-names>E.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fr&#237;as</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><article-title>Dynamics of
Lanthanide&#173;(III) Complexes
from Crystallographic Data and Computational Studies</article-title><source>Inorg. Chem. Commun.</source><year>2024</year><volume>170</volume><elocation-id>113348</elocation-id><pub-id pub-id-type="doi">10.1016/j.inoche.2024.113348</pub-id></element-citation></ref><ref id="ref61"><element-citation publication-type="journal" id="cit61"><name name-style="western"><surname>Souri</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>K.-L.</given-names></name><name name-style="western"><surname>Nonat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Charbonni&#232;re</surname><given-names>L. J.</given-names></name><article-title>Upconverted
Photosensitization of
Tb Visible Emission by NIR Yb Excitation in Discrete Supramolecular
Heteropolynuclear Complexes</article-title><source>J. Am. Chem. Soc.</source><year>2017</year><volume>139</volume><issue>4</issue><fpage>1456</fpage><lpage>1459</lpage><pub-id pub-id-type="doi">10.1021/jacs.6b12940</pub-id><pub-id pub-id-type="pmid">28092442</pub-id></element-citation></ref><ref id="ref62"><element-citation publication-type="journal" id="cit62"><name name-style="western"><surname>Thakur</surname><given-names>P.</given-names></name><name name-style="western"><surname>Conca</surname><given-names>J. L.</given-names></name><name name-style="western"><surname>Dodge</surname><given-names>C. J.</given-names></name><name name-style="western"><surname>Francis</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Choppin</surname><given-names>G. R.</given-names></name><article-title>Complexation
Thermodynamics and Structural Studies of Trivalent Actinide and Lanthanide
Complexes with DTPA, MS-325 and HMDTPA</article-title><source>Radiochim.
Acta</source><year>2013</year><volume>101</volume><issue>4</issue><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1524/ract.2013.2018</pub-id></element-citation></ref><ref id="ref63"><element-citation publication-type="journal" id="cit63"><name name-style="western"><surname>Regueiro-Figueroa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bensenane</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ruscs&#225;k</surname><given-names>E.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Charbonni&#232;re</surname><given-names>L. J.</given-names></name><name name-style="western"><surname>Tircs&#243;</surname><given-names>G.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>I.</given-names></name><name name-style="western"><surname>Blas</surname><given-names>A. de.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Blas</surname><given-names>T.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><article-title>Lanthanide Dota-like Complexes Containing a Picolinate
Pendant: Structural Entry for the Design of Ln<sup>III</sup> -Based
Luminescent Probes</article-title><source>Inorg. Chem.</source><year>2011</year><volume>50</volume><issue>9</issue><fpage>4125</fpage><lpage>4141</lpage><pub-id pub-id-type="doi">10.1021/ic2001915</pub-id><pub-id pub-id-type="pmid">21456610</pub-id></element-citation></ref><ref id="ref64"><element-citation publication-type="journal" id="cit64"><name name-style="western"><surname>Roca-Sabio</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mato-Iglesias</surname><given-names>M.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>&#201;.</given-names></name><name name-style="western"><surname>Blas</surname><given-names>A. de.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Blas</surname><given-names>T.</given-names></name><article-title>Macrocyclic
Receptor Exhibiting Unprecedented Selectivity for Light Lanthanides</article-title><source>J. Am. Chem. Soc.</source><year>2009</year><volume>131</volume><issue>9</issue><fpage>3331</fpage><lpage>3341</lpage><pub-id pub-id-type="doi">10.1021/ja808534w</pub-id><pub-id pub-id-type="pmid">19256570</pub-id></element-citation></ref><ref id="ref65"><element-citation publication-type="journal" id="cit65"><name name-style="western"><surname>Blei</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Waurick</surname><given-names>L.</given-names></name><name name-style="western"><surname>Reissig</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kopka</surname><given-names>K.</given-names></name><name name-style="western"><surname>Stumpf</surname><given-names>T.</given-names></name><name name-style="western"><surname>Drobot</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kretzschmar</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mamat</surname><given-names>C.</given-names></name><article-title>Equilibrium Thermodynamics
of Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical
Interest</article-title><source>Inorg. Chem.</source><year>2023</year><volume>62</volume><issue>50</issue><fpage>20699</fpage><lpage>20709</lpage><pub-id pub-id-type="doi">10.1021/acs.inorgchem.3c01983</pub-id><pub-id pub-id-type="pmid">37702665</pub-id><pub-id pub-id-type="pmcid">PMC10731647</pub-id></element-citation></ref><ref id="ref66"><element-citation publication-type="journal" id="cit66"><name name-style="western"><surname>Harris</surname><given-names>W. R.</given-names></name><name name-style="western"><surname>Raymond</surname><given-names>K. N.</given-names></name><name name-style="western"><surname>Weitl</surname><given-names>F. L.</given-names></name><article-title>Ferric
Ion Sequestering Agents. 6.
The Spectrophotometric and Potentiometric Evaluation of Sulfonated
Tricatecholate Ligands</article-title><source>J. Am. Chem. Soc.</source><year>1981</year><volume>103</volume><issue>10</issue><fpage>2667</fpage><lpage>2675</lpage><pub-id pub-id-type="doi">10.1021/ja00400a030</pub-id></element-citation></ref><ref id="ref67"><element-citation publication-type="journal" id="cit67"><name name-style="western"><surname>Hellman</surname><given-names>N. E.</given-names></name><name name-style="western"><surname>Gitlin</surname><given-names>J. D.</given-names></name><article-title>CERULOPLASMIN METABOLISM AND FUNCTION</article-title><source>Annu. Rev. Nutr.</source><year>2002</year><volume>22</volume><issue>1</issue><fpage>439</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1146/annurev.nutr.22.012502.114457</pub-id><pub-id pub-id-type="pmid">12055353</pub-id></element-citation></ref><ref id="ref68"><element-citation publication-type="journal" id="cit68"><name name-style="western"><surname>Falcone</surname><given-names>E.</given-names></name><name name-style="western"><surname>Faller</surname><given-names>P.</given-names></name><article-title>Thermodynamics-Based
Rules of Thumb to Evaluate the
Interaction of Chelators and Kinetically-Labile Metal Ions in Blood
Serum and Plasma</article-title><source>Dalton Trans.</source><year>2023</year><volume>52</volume><issue>8</issue><fpage>2197</fpage><lpage>2208</lpage><pub-id pub-id-type="doi">10.1039/D2DT03875G</pub-id><pub-id pub-id-type="pmid">36734607</pub-id></element-citation></ref><ref id="ref69"><element-citation publication-type="journal" id="cit69"><name name-style="western"><surname>Bossak-Ahmad</surname><given-names>K.</given-names></name><name name-style="western"><surname>Fr&#261;czyk</surname><given-names>T.</given-names></name><name name-style="western"><surname>Bal</surname><given-names>W.</given-names></name><name name-style="western"><surname>Drew</surname><given-names>S. C.</given-names></name><article-title>The Sub-Picomolar
Cu<sup>2+</sup> Dissociation Constant of Human Serum Albumin</article-title><source>ChemBioChem</source><year>2020</year><volume>21</volume><issue>3</issue><fpage>331</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1002/cbic.201900435</pub-id><pub-id pub-id-type="pmid">31298451</pub-id></element-citation></ref><ref id="ref70"><element-citation publication-type="journal" id="cit70"><name name-style="western"><surname>Lucio-Mart&#237;nez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Szil&#225;gyi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Uzal-Varela</surname><given-names>R.</given-names></name><name name-style="western"><surname>P&#233;rez-Lourido</surname><given-names>P.</given-names></name><name name-style="western"><surname>Esteban-G&#243;mez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lepareur</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tircs&#243;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Platas-Iglesias</surname><given-names>C.</given-names></name><article-title>[<sup>nat</sup>Y/<sup>90</sup> Y]Yttrium and [<sup>nat</sup>Lu/<sup>177</sup>Lu]Lutetium Complexation by Rigid H<sub>4</sub>OCTAPA Derivatives. Effect of Ligand Topology</article-title><source>Chem. - Eur. J.</source><year>2025</year><volume>31</volume><elocation-id>e202500799</elocation-id><pub-id pub-id-type="doi">10.1002/chem.202500799</pub-id><pub-id pub-id-type="pmid">40178154</pub-id></element-citation></ref><ref id="ref71"><element-citation publication-type="journal" id="cit71"><name name-style="western"><surname>Baranyai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>P&#225;link&#225;s</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Uggeri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Maiocchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Aime</surname><given-names>S.</given-names></name><name name-style="western"><surname>Br&#252;cher</surname><given-names>E.</given-names></name><article-title>Dissociation Kinetics of Open-Chain
and Macrocyclic Gadolinium&#173;(III)-Aminopolycarboxylate Complexes Related
to Magnetic Resonance Imaging: Catalytic Effect of Endogenous Ligands</article-title><source>Chem. - Eur. J.</source><year>2012</year><volume>18</volume><issue>51</issue><fpage>16426</fpage><lpage>16435</lpage><pub-id pub-id-type="doi">10.1002/chem.201202930</pub-id><pub-id pub-id-type="pmid">23139193</pub-id></element-citation></ref><ref id="ref72"><element-citation publication-type="journal" id="cit72"><name name-style="western"><surname>Baranyai</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Br&#252;cher</surname><given-names>E.</given-names></name><name name-style="western"><surname>Uggeri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Maiocchi</surname><given-names>A.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>I.</given-names></name><name name-style="western"><surname>Andr&#225;si</surname><given-names>M.</given-names></name><name name-style="western"><surname>G&#225;sp&#225;r</surname><given-names>A.</given-names></name><name name-style="western"><surname>Z&#233;k&#225;ny</surname><given-names>L.</given-names></name><name name-style="western"><surname>Aime</surname><given-names>S.</given-names></name><article-title>The Role of Equilibrium and Kinetic Properties in the Dissociation
of Gd&#173;[DTPA-Bis&#173;(Methylamide)] (Omniscan) at near to Physiological Conditions</article-title><source>Chem. - Eur. J.</source><year>2015</year><volume>21</volume><issue>12</issue><fpage>4789</fpage><lpage>4799</lpage><pub-id pub-id-type="doi">10.1002/chem.201405967</pub-id><pub-id pub-id-type="pmid">25678406</pub-id></element-citation></ref><ref id="ref73"><element-citation publication-type="journal" id="cit73"><name name-style="western"><surname>Zak</surname><given-names>O.</given-names></name><name name-style="western"><surname>Aisen</surname><given-names>P.</given-names></name><article-title>Spectroscopic and Thermodynamic
Studies on the Binding of Gadolinium&#173;(III)
to Human Serum Transferrin</article-title><source>Biochemistry</source><year>1988</year><volume>27</volume><issue>3</issue><fpage>1075</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1021/bi00403a033</pub-id><pub-id pub-id-type="pmid">2835077</pub-id></element-citation></ref><ref id="ref74"><element-citation publication-type="journal" id="cit74"><name name-style="western"><surname>S&#248;rensen</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Faulkner</surname><given-names>S.</given-names></name><article-title>Multimetallic Lanthanide Complexes: Using Kinetic Control
To Define Complex Multimetallic Arrays</article-title><source>Acc.
Chem. Res.</source><year>2018</year><volume>51</volume><issue>10</issue><fpage>2493</fpage><lpage>2501</lpage><pub-id pub-id-type="doi">10.1021/acs.accounts.8b00205</pub-id><pub-id pub-id-type="pmid">30222311</pub-id></element-citation></ref><ref id="ref75"><element-citation publication-type="journal" id="cit75"><name name-style="western"><surname>Eckelman</surname><given-names>W. C.</given-names></name><article-title>The Use
of in Vitro Models to Predict the Distribution of Receptor Binding
Radiotracers in Vivo</article-title><source>Int. J. Radiat. Appl.
Instrum., Part B</source><year>1989</year><volume>16</volume><issue>3</issue><fpage>233</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/0883-2897(89)90004-4</pub-id><pub-id pub-id-type="pmid">2541113</pub-id></element-citation></ref><ref id="ref76"><element-citation publication-type="journal" id="cit76"><name name-style="western"><surname>Irving</surname><given-names>H. M.</given-names></name><name name-style="western"><surname>Miles</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Pettit</surname><given-names>L. D.</given-names></name><article-title>A Study of Some
Problems in Determining
the Stoichiometric Proton Dissociation Constants of Complexes by Potentiometric
Titrations Using Glass Electrode</article-title><source>Anal. Chim.
Acta</source><year>1967</year><volume>38</volume><fpage>475</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/S0003-2670(01)80616-4</pub-id></element-citation></ref><ref id="ref77"><mixed-citation publication-type="book" id="cit77"><article-title>PSEQUAD</article-title>. In <source>Computational Methods for the
Determination of Formation Constants; Modern Inorganic Chemistry</source>; <publisher-name>Springer</publisher-name>: <publisher-loc>Boston,
MA</publisher-loc>, <year>1985</year>.</mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="book" id="cit78"><source>APEX4</source>, <publisher-name>Bruker AXS Inc</publisher-name>. <publisher-loc>Madison, Wisconsin</publisher-loc>, <year>2021</year>.</mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="book" id="cit79"><source>SAINT Version 8.37A</source>; <publisher-name>Bruker AXS Inc</publisher-name>; <publisher-loc>Madison, Wisconsin</publisher-loc>, <year>2015</year>.</mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="book" id="cit80"><person-group person-group-type="allauthors"><string-name name-style="western"><surname>Sheldrick</surname>, <given-names>G. M.</given-names></string-name></person-group><source>SADABS, Version 2.10</source>; <publisher-name>University of G&#246;ttingen</publisher-name>, <publisher-loc>Germany</publisher-loc>, <year>2004</year>.</mixed-citation></ref><ref id="ref81"><element-citation publication-type="journal" id="cit81"><name name-style="western"><surname>Sheldrick</surname><given-names>G. M.</given-names></name><article-title>Crystal
Structure Refinement with <italic toggle="yes">SHELXL</italic>, Version 2014/5</article-title><source>Acta Crystallogr., Sect. C:Struct. Chem.</source><year>2015</year><volume>71</volume><issue>1</issue><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1107/S2053229614024218</pub-id><pub-id pub-id-type="pmid">25567568</pub-id><pub-id pub-id-type="pmcid">PMC4294323</pub-id></element-citation></ref><ref id="ref82"><element-citation publication-type="journal" id="cit82"><name name-style="western"><surname>Sheldrick</surname><given-names>G. M.</given-names></name><article-title>A Short
History of <italic toggle="yes">SHELX</italic>
</article-title><source>Acta Crystallogr.,
Sect. A</source><year>2008</year><volume>64</volume><issue>1</issue><fpage>112</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1107/S0108767307043930</pub-id><pub-id pub-id-type="pmid">18156677</pub-id></element-citation></ref><ref id="ref83"><element-citation publication-type="journal" id="cit83"><name name-style="western"><surname>Dolomanov</surname><given-names>O. V.</given-names></name><name name-style="western"><surname>Bourhis</surname><given-names>L. J.</given-names></name><name name-style="western"><surname>Gildea</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Howard</surname><given-names>J. A. K.</given-names></name><name name-style="western"><surname>Puschmann</surname><given-names>H.</given-names></name><article-title>
<italic toggle="yes">OLEX2</italic>: A Complete Structure Solution,
Refinement and Analysis Program</article-title><source>J. Appl. Crystallogr.</source><year>2009</year><volume>42</volume><issue>2</issue><fpage>339</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1107/S0021889808042726</pub-id></element-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>